<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2025.1613760</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Advances in adhesion-related pathogenesis in <italic>Mycoplasma pneumoniae</italic> infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sun</surname> <given-names>Bingyue</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2136666/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ling</surname> <given-names>Yaozheng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2092664/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Junhui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ma</surname> <given-names>Li</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2250181/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jie</surname> <given-names>Zige</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Luo</surname> <given-names>Hongbing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Yang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yin</surname> <given-names>Guo</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Mingwei</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Meng</surname> <given-names>Fanzheng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gao</surname> <given-names>Man</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pediatric Respiration, Children&#x2019;s Medical Center, The First Hospital of Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Developmental and Behavioral Pediatrics, The First Hospital of Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>The First Hospital of Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Center for Pathogen Biology and Infectious Diseases, The First Hospital of Jilin University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Xia Cai, Fudan University, China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Claudia Guadalupe Benitez-Cardoza, National Polytechnic Institute, Mexico</p>
<p>Peng Liu, University of South China, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Fanzheng Meng, <email>fzmeng@jlu.edu.cn</email></corresp>
<corresp id="c002">Man Gao, <email>gao_man@jlu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1613760</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Sun, Ling, Li, Ma, Jie, Luo, Li, Yin, Wang, Meng and Gao.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Sun, Ling, Li, Ma, Jie, Luo, Li, Yin, Wang, Meng and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p><italic>Mycoplasma pneumoniae</italic> is a leading cause of community-acquired pneumonia (CAP) and upper respiratory tract infections, particularly in children and immunocompromised individuals. The growing global prevalence of macrolide-resistant <italic>M. pneumoniae</italic> (MRMP) further emphasizes the urgent need to elucidate its pathogenic mechanisms. Among these, adhesion plays a central role, serving as a prerequisite for colonization and disease progression, and thus warrants detailed investigation. The terminal organelle of <italic>M. pneumoniae</italic> mediates both adhesion and gliding motility, facilitating colonization, tissue invasion, and potential systemic spread. In the lung, adhesion triggers cytotoxic effects through the release of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and CARDS toxin (CARDS TX), promotes excessive inflammatory responses, and enables immune evasion via antigenic variation. Extrapulmonary manifestations may also arise either from direct bacterial dissemination or autoimmune responses induced by molecular mimicry between bacterial and host antigens. In addition, recent advances suggest that therapies and vaccines directed at the adhesion mechanism of <italic>M. pneumoniae</italic> may offer promising strategies for combating MRMP infections. Although progress has been made, the adhesion-related pathogenesis of <italic>M. pneumoniae</italic>, as well as the prospects for therapies and vaccines targeting this mechanism, remains incompletely defined. This review synthesizes current insights into adhesion-mediated mechanisms and highlights emerging therapeutic strategies targeting adhesion, aiming to support more effective treatment and prevention of <italic>M. pneumoniae</italic> infection.</p>
</abstract>
<kwd-group>
<kwd><italic>M. pneumonia</italic></kwd>
<kwd>terminal organelle</kwd>
<kwd>adhesion</kwd>
<kwd>treatment</kwd>
<kwd>vaccines</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="148"/>
<page-count count="17"/>
<word-count count="13422"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Agents and Disease</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>1 Introduction</title>
<p><italic>Mycoplasma pneumoniae</italic> (<italic>M. pneumoniae</italic>), a minimalist bacterial pathogen with a streamlined genetic architecture, possesses one of the smallest genomes among free-living organisms, spanning about 816 kilobase pairs (kbp). This genomic reduction reflects its evolutionary adaptation to obligate parasitism in the human respiratory tract and makes it a valuable model for studying host&#x2013;pathogen interactions in genome-limited microbes (<xref ref-type="bibr" rid="B69">Kumar, 2018</xref>). Despite lacking a cell wall, <italic>M. pneumoniae</italic> has evolved a structurally optimized triple-layered membrane enriched with sterols and transmembrane proteins, which confers intrinsic resistance to &#x03B2;-lactam antibiotics that target peptidoglycan synthesis (<xref ref-type="bibr" rid="B87">Meseguer et al., 2003</xref>). Its genomic core houses essential macromolecular complexes, including a covalently closed circular DNA genome, RNA polymerase (RNAP), ribosomes, and mRNAs, which collectively drive its streamlined transcriptional-translational machinery. Critically, the transcription elongation factor N-utilizing substance A (NusA) mediates dynamic coupling between RNAP and ribosomes through direct physical interactions, synchronizing transcription with translation to ensure rapid gene expression (<xref ref-type="bibr" rid="B87">Meseguer et al., 2003</xref>; <xref ref-type="bibr" rid="B74">Liang et al., 2012</xref>; <xref ref-type="bibr" rid="B100">O&#x2019;Reilly et al., 2020</xref>).</p>
<p><italic>M. pneumoniae</italic>, which is globally distributed, is a common cause of community-acquired pneumonia (CAP), which accounts for about 10&#x2013;30% of all CAP cases and upper respiratory tract (URT) infections, particularly in children and immunocompromised adolescents (<xref ref-type="bibr" rid="B141">Yoon et al., 2017</xref>). Although <italic>M. pneumoniae</italic> pneumonia (MPP) is considered a self-limiting disease, it causes various pulmonary symptoms, such as fever, dry cough, dyspnea, and wheezing, along with several complications, such as atelectasis and pleural effusion (<xref ref-type="bibr" rid="B36">Hawkins et al., 2011</xref>; <xref ref-type="bibr" rid="B146">Zhang et al., 2020</xref>). Additionally, refractory <italic>M. pneumoniae</italic> pneumonia (RMPP) has been increasingly reported and may be accompanied by severe necrotizing pneumonia, bronchitis obliterans, thrombosis, etc. RMPP is more common in children than in adults, with a rising incidence rate (<xref ref-type="bibr" rid="B78">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="B145">Zhai et al., 2020</xref>). These infections not only impose a considerable medical burden on humans but can also induce severe sequelae, such as bronchiolitis obliterans, atelectasis, and bronchiectasis (<xref ref-type="bibr" rid="B44">Huang et al., 2018</xref>). <italic>M. pneumoniae</italic> infection also causes a wide range of extrapulmonary diseases involving multiple systems, including the cutaneous, musculoskeletal, neurological, hematological, digestive, and renal systems (<xref ref-type="bibr" rid="B106">Poddighe, 2018</xref>; <xref ref-type="bibr" rid="B43">Hu et al., 2022</xref>). Meanwhile, the widespread prevalence of macrolide resistant <italic>M. pneumoniae</italic> (MRMP) poses a great challenge to resist <italic>M. pneumoniae</italic> (<xref ref-type="bibr" rid="B46">Jiang F. C. et al., 2021</xref>). To better understand and treat MPP/RMPP-related diseases and other extrapulmonary diseases caused by <italic>M. pneumoniae</italic>, we aimed to further elucidate the pathogenesis of <italic>M. pneumoniae</italic>.</p>
<p>According to previous research, the possible pathogenesis of <italic>M. pneumoniae</italic> includes adhesion damage, destruction of membrane fusion, nutrient depletion, toxic injuries, inflammatory injuries, and other immune-related injuries (<xref ref-type="bibr" rid="B37">He et al., 2016</xref>; <xref ref-type="bibr" rid="B140">Yiwen et al., 2021</xref>). Among these, pathogen adhesion to host cells is a critical virulence factor, facilitating microbial colonization by evading mucociliary clearance and immune surveillance, and establishing the basis for subsequent invasion (<xref ref-type="bibr" rid="B130">Vaca et al., 2020</xref>). Specifically, the adherence of <italic>M. pneumoniae</italic> to the respiratory epithelium is a key step in initiating infection, allowing the release of cytotoxins, tissue damage, and immune evasion (<xref ref-type="bibr" rid="B60">Kashyap and Sarkar, 2010</xref>).</p>
<p>Despite its critical role in infection, the precise pathogenesis involving <italic>M. pneumoniae</italic> adhesion remains elusive. Therefore, this review systematically synthesizes current findings on the role of adhesion mechanisms in <italic>M. pneumoniae</italic>-host interactions and outlines future research directions to support the development of improved prevention and treatment strategies.</p>
</sec>
<sec id="S2">
<title>2 Adhesion and gliding mechanisms of <italic>M. pneumoniae</italic></title>
<sec id="S2.SS1">
<title>2.1 The adhesion mechanisms of <italic>M. pneumoniae</italic></title>
<sec id="S2.SS1.SSS1">
<title>2.1.1 Structure of the terminal organelle</title>
<p>The terminal organelle of <italic>M. pneumoniae</italic>, also referred to as the attachment organelle or tip structure (<xref ref-type="bibr" rid="B94">Miyata and Hamaguchi, 2016</xref>), orchestrates both cytoadherence to host epithelia and gliding motility, which are essential for tissue dissemination (<xref ref-type="bibr" rid="B66">Krause et al., 2018</xref>; <xref ref-type="bibr" rid="B134">Widjaja et al., 2020</xref>). This specialized polar membrane protrusion has a bipartite architecture: surface-exposed nap-like proteins facilitate host-pathogen interactions, and an intricately organized internal structure enables the generation of mechanical force (<xref ref-type="bibr" rid="B95">Nakane et al., 2015</xref>). The adhesion machinery of terminal organelles comprises four evolutionarily conserved surface proteins that mediate gliding and adhesion mechanisms: P1 (MPN141), P90/P40 (encoded by MPN142 as proteolytic cleavage products), and P30 (MPN453). Spatial mapping has demonstrated that the P1 adhesin complex, comprising the P1 and P90/P40 subunits, is strategically localized at the apical tip of the organelle, forming a rigid membrane anchor. Whereas P30 dynamically associates with the complex periphery to regulate force transduction during gliding motility (<xref ref-type="bibr" rid="B95">Nakane et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Miyata and Hamaguchi, 2016</xref>; <xref ref-type="bibr" rid="B148">Zuo et al., 2024</xref>). Internally, the terminal organelle exhibits a sophisticated internal architecture comprising an electron-dense core structure that maintains structural integrity through three specialized components: the terminal button, paired plates, and bowl complex. This core is enveloped by a translucent matrix region. This highly organized core scaffold provides mechanical stability and serves as an assembly platform for the adhesion machinery. The terminal button, situated within the inner peripheral membrane region, is primarily composed of three core proteins: P65 (MPN309), HMW2 (MPN310), and HMW3 (MPN452). Adjacent to this structure, the paired plates system has a stratified organization consisting of four distinct components: HMW1 (MPN447), HMW2 (MPN310), CpsG (MPN066), and HMW3 (MPN452). The paired plates exhibit distinct protein compositions across their morphological subtypes: the thin plates are primarily composed of HMW1 and CpsG, whereas the thick plates are enriched in HMW2. The plate complex occupies a posterior position within the organelle architecture, where the thick and thin plates form an integrated unit through direct adhesion. This composite structure establishes stable connections with bowl-shaped structural elements through precise molecular interactions. Structural analysis of the coiled HMW2 protein revealed critical functional domains: its N-terminal region mediates attachment to the terminal button complex, whereas the C-terminal domain facilitates integration with the bowl structure. This bipolar molecular configuration suggests that HMW2 serves as a key architectural element that bridges distinct organellar components (<xref ref-type="bibr" rid="B62">Kawamoto et al., 2016</xref>). The bowl complex itself is composed of seven core components: TopJ (MPN119), P24 (MPN312), Lon protease (MPN332), P200 (MPN567), MPN387, P41 (MPN311), and HMW2 (MPN310) (<xref ref-type="bibr" rid="B95">Nakane et al., 2015</xref>; <xref ref-type="bibr" rid="B94">Miyata and Hamaguchi, 2016</xref>). MPN387 is specifically localized at the interface between the plates and bowl, suggesting a potential coordinating function. The translucent area occupied by a rigid, electronically transparent substance transmits the force generated by the bowl complex to paired plates (<xref ref-type="bibr" rid="B6">Balish et al., 2003</xref>; <xref ref-type="bibr" rid="B62">Kawamoto et al., 2016</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). As discussed above, the terminal organelle is a highly organized and functionally coordinated structure, and the specific roles of its components are further detailed below.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p><bold>(A)</bold> A pattern map of the terminal organelle&#x2019;s structures. <bold>(B)</bold> The structures of the proteins in the terminal organelle and their relative positions. The 3D structures of the proteins are visualized by PyMOL software based on their amino acid sequences from NCBI, while their relative positions are described based on the core image and recent mapping results from Hamaguchi (2016).</p></caption>
<alt-text>Diagram illustrating the terminal organelle of Mycoplasma pneumoniae. Panel A shows its components, including the bowl complex, paired plates, terminal button, and proteins P1, P90/P40, and P30. Panel B presents the 3D protein structures: Lon, TopJ, P41, CpsG, HMW1, HMW2, HMW3, P65, and others, displayed in blue, green, and purple, with P90/P40, P30, and P1 highlighted below.</alt-text>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1613760-g001.tif"/>
</fig>
</sec>
<sec id="S2.SS1.SSS2">
<title>2.1.2 Adhesion mechanisms of the terminal organelle</title>
<p>Sialylated oligosaccharides (SOS) are the terminal glycan modifications that cap the outer branches of glycoconjugates on cell surface-associated glycoproteins and glycolipids. They also serve as essential structural components of mucosal glycoproteins within mucus layers (<xref ref-type="bibr" rid="B93">Miyata, 2008</xref>; <xref ref-type="bibr" rid="B59">Kasai et al., 2013</xref>; <xref ref-type="bibr" rid="B5">Balish, 2014</xref>). Glycoproteins, a class of macromolecules ubiquitously present in biological systems, are strategically localized on the plasma membranes, within the extracellular matrix, and throughout bodily fluids. They exhibit functional diversity across processes such as molecular recognition, immune modulation, and intercellular communication. Among these functions, cell adhesion is primarily mediated by two major families of glycoproteins: integrins and cadherins (<xref ref-type="bibr" rid="B11">Chastney et al., 2025</xref>; <xref ref-type="bibr" rid="B47">Jiang et al., 2025</xref>). In microbial infection, SOS, which serve as key receptor molecules on the surface of host cells and within the mucus layer, are specifically recognized by a variety of pathogenic microorganisms and exploited to facilitate adhesion and invasion (<xref ref-type="table" rid="T1">Table 1</xref>; <xref ref-type="bibr" rid="B122">Spahich and St Geme, 2011</xref>; <xref ref-type="bibr" rid="B40">Hentrich et al., 2016</xref>; <xref ref-type="bibr" rid="B2">Andreae et al., 2018</xref>; <xref ref-type="bibr" rid="B82">Marc et al., 2018</xref>; <xref ref-type="bibr" rid="B42">Hong et al., 2022</xref>; <xref ref-type="bibr" rid="B109">Pronker et al., 2023</xref>; <xref ref-type="bibr" rid="B1">Aberg et al., 2024</xref>; <xref ref-type="bibr" rid="B99">Ni et al., 2024</xref>). Similarly, <italic>M. pneumoniae</italic> utilizes the terminal organelle to bind to SOS in a &#x201C;lock-and-key&#x201D; pattern to initiate its adhesion. Both &#x03B1;-2,6- and &#x03B1;-2,3-sialyllactose support the adherence of <italic>M. pneumoniae</italic>, of which &#x03B1;-2,3-sialyllactose has a relatively high affinity (<xref ref-type="bibr" rid="B136">Williams et al., 2020</xref>; <xref ref-type="bibr" rid="B132">Vizarraga et al., 2021</xref>). The interaction between <italic>M. pneumoniae</italic> and SOS on glycoproteins distributed across multiple organs and tissues may represent a fundamental pathogenic mechanism contributing to the multi-system involvement in <italic>M. pneumoniae</italic> infections.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Microbial pathogens employ adhesion strategies to establish host colonization.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Species</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Name</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">Mechanism</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center" rowspan="4">Bacteria</td>
<td valign="top" align="center"><italic>Hemophilus influenzae</italic></td>
<td valign="top" align="center">Binding of surface adhesin proteins (Hia, Hsf) to the SOS in host respiratory epithelial cells to mediate respiratory colonization.</td>
</tr>
<tr>
<td valign="top" align="center"><italic>Streptococcus pneumoniae</italic></td>
<td valign="top" align="center">Secretory neuraminidase (NanA) cleaves sialic acid residues, exposing underlying receptors to promote colonization.</td>
</tr>
<tr>
<td valign="top" align="center"><italic>Neisseria meningitidis</italic></td>
<td valign="top" align="center">Using outer membrane proteins Opa and OpC to bind to host receptors, such as sialated CD46, to promote blood-brain barrier crossing.</td>
</tr>
<tr>
<td valign="top" align="center"><italic>Helicobacter pylori</italic></td>
<td valign="top" align="center">SabA adhesin specifically recognizes sLex/a in the gastric mucosal layer to mediate gastric epithelial adhesion and chronic infection.</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="2">Virus</td>
<td valign="top" align="center"><italic>Influenza virus</italic></td>
<td valign="top" align="center">Hemagglutinin (HA) protein recognizes the sialic acid receptor on the host cell surface to initiate infection.</td>
</tr>
<tr>
<td valign="top" align="center"><italic>SARS-CoV-2</italic></td>
<td valign="top" align="center">Indirectly promoting membrane fusion through histone proteins released by neutrophils, linking the spike protein and sialic acid.</td>
</tr>
<tr>
<td valign="top" align="center">Fungi</td>
<td valign="top" align="center"><italic>Candida albicans</italic></td>
<td valign="top" align="center">Surface lectin-like sequence (ALS) family proteins bind to host sialoglycans to promote biofilm formation and tissue invasion.</td>
</tr>
</tbody>
</table></table-wrap>
<p>In <italic>M. pneumoniae</italic>, multiple adhesin proteins localized within the terminal organelle contribute to its attachment to host cells. Among them, P1 functions as the primary adhesin and plays a central role in mediating the bacteria-host interaction. Strains lacking P1 entirely lose their adhesion capability and consequently become non-pathogenic. Through the action of the P1 adhesin, <italic>M. pneumoniae</italic> attaches to host epithelial cells and localizes within intercellular spaces, thereby evading ciliary clearance and macrophage phagocytosis. This allows the pathogen to release virulence factors and inflict damage on host tissues (<xref ref-type="bibr" rid="B37">He et al., 2016</xref>; <xref ref-type="bibr" rid="B134">Widjaja et al., 2020</xref>). Although P1 adhesin is an essential component for both adhesion and gliding, it can mediate binding between <italic>M. pneumoniae</italic> and host receptors only when correctly localized on the terminal organelle (<xref ref-type="bibr" rid="B134">Widjaja et al., 2020</xref>). One accessory protein, the DnaJ-like chaperone TopJ, which contains a J-domain, an acidic- and proline-rich region (APR), and a C-terminal domain, efficiently facilitates the delivery of P1 to the surface of the terminal organelle (<xref ref-type="bibr" rid="B16">Cloward and Krause, 2010</xref>, <xref ref-type="bibr" rid="B17">2011</xref>). In addition, the P90/P40 adhesins of <italic>M. pneumoniae</italic> also exhibit specific binding affinity to the terminal sialylated glycans of host oligosaccharides. P90/P40 proteins associate with P1 adhesin to form an adhesin complex that further enhances the adhesive properties of <italic>M. pneumoniae</italic> (<xref ref-type="bibr" rid="B64">Kenri et al., 2008</xref>; <xref ref-type="bibr" rid="B139">Yamazaki and Kenri, 2016</xref>; <xref ref-type="bibr" rid="B63">Kenri et al., 2019</xref>; <xref ref-type="bibr" rid="B131">Vizarraga et al., 2020</xref>; <xref ref-type="bibr" rid="B83">Marseglia et al., 2024</xref>). P30, another membrane protein, has been shown to localize at the distal end of the terminal organelle. Research suggested that P30, with a homologous sequence of P1 in a certain domain, implies a potential beneficial association for adhesion (<xref ref-type="bibr" rid="B94">Miyata and Hamaguchi, 2016</xref>). Notably, P30 and P65 exhibit a close functional and spatial relationship, wherein P65 interacts with the internal domain of P30 to mediate precise contact between the terminal button and the frontal region of the structural layer (<xref ref-type="bibr" rid="B94">Miyata and Hamaguchi, 2016</xref>). Furthermore, the P41 protein governs the polar localization of the terminal organelle and directs the positioning of P24 within the adhesion complex. Together, P41 and P24 ensure proper spatial organization of the adhesin machinery, thereby facilitating effective host adhesion (<xref ref-type="bibr" rid="B33">Hasselbring and Krause, 2007</xref>; <xref ref-type="bibr" rid="B66">Krause et al., 2018</xref>).</p>
<p>Additionally, the HMW1, HMW2, and HMW3 proteins can also contribute to the adhesion of <italic>M. pneumoniae</italic> to the airway epithelium (<xref ref-type="bibr" rid="B101">Page and Krause, 2013</xref>). The loss of HMW1 results in a deletion at the 3&#x2019; end of the p30 gene and disrupts the functional association among HMW2, HMW3, and P65. This disruption consequently impairs the clustering of P1 at the cell&#x2019;s polar end, thereby weakening the adhesive capacity. Furthermore, dysfunction of HMW3 suppresses P65 expression and causes its diffuse localization, preventing proper positioning of the P1 adhesin at the terminal organelle and further reducing adhesion efficiency (<xref ref-type="bibr" rid="B31">Hahn et al., 1998</xref>; <xref ref-type="bibr" rid="B135">Willby and Krause, 2002</xref>).</p>
</sec>
<sec id="S2.SS1.SSS3">
<title>2.1.3 Adhesion mechanisms of adherence factors</title>
<p>While the terminal organelle is essential for primary adherence, <italic>M. pneumoniae</italic> also expresses adhesion factors that function independently of this structure. Notably, several surface-exposed glycolytic enzymes have recently been identified as non-classical adhesins involved in host-pathogen interactions (<xref ref-type="bibr" rid="B28">Grundel et al., 2015</xref>). These enzymes, including lactate dehydrogenase (LDH), phosphoglycerate mutase (PGM), pyruvate kinase (PYK), glyceraldehyde-3-phosphate dehydrogenase (GapA), transketolase (TKT), and pyruvate dehydrogenase subunits A to C (PdhA-C), have been shown to interact with components of the extracellular matrix (ECM), thereby contributing to both adhesion and invasion processes of <italic>M. pneumoniae</italic> (<xref ref-type="bibr" rid="B128">Thomas et al., 2013</xref>; <xref ref-type="bibr" rid="B30">Gr&#x00FC;ndel et al., 2015</xref>; <xref ref-type="bibr" rid="B29">Grundel et al., 2016</xref>; <xref ref-type="bibr" rid="B26">Grimmer and Dumke, 2019</xref>). In addition, elongation factor Tu (MPN665, EF-Tu), a well-known moonlighting protein with multiple non-overlapping functions, has been identified on the surface of <italic>M. pneumoniae</italic> in several studies (<xref ref-type="bibr" rid="B19">Dallo et al., 2002</xref>; <xref ref-type="bibr" rid="B4">Balasubramanian et al., 2008</xref>). Besides its canonical role in cytoplasmic biosynthesis and metabolism, EF-Tu has also been shown to bind fibronectin (Fn), thereby mediating the interaction between <italic>M. pneumoniae</italic> and the ECM (<xref ref-type="bibr" rid="B19">Dallo et al., 2002</xref>; <xref ref-type="bibr" rid="B4">Balasubramanian et al., 2008</xref>; <xref ref-type="bibr" rid="B26">Grimmer and Dumke, 2019</xref>). The ECM consists of two major components: the interstitial connective tissue matrix, which provides structural support, and the basement membrane, a specialized layer that regulates cellular organization and differentiation (<xref ref-type="bibr" rid="B58">Karamanos et al., 2021</xref>). Interactions between host cells and the ECM are primarily mediated by laminin (Ln) within the basement membrane, as well as by interstitial matrix proteins such as Fn, vitronectin (Vn), and fibrinogen (<xref ref-type="bibr" rid="B29">Grundel et al., 2016</xref>). Integrins, a ubiquitous family of transmembrane receptor proteins expressed on human cells, recognize Arg-Gly-Asp (RGD) motifs within these ECM components and facilitate cellular anchorage through bidirectional mechanotransduction (<xref ref-type="bibr" rid="B126">Sutherland et al., 2023</xref>). When surface-associated glycolytic enzymes of <italic>M. pneumoniae</italic> bind to these ECM proteins, they function as bacterial ligands that interact with host cell receptors, thereby enhancing the adhesion of <italic>M. pneumoniae</italic> to respiratory epithelial cells (<xref ref-type="bibr" rid="B7">Bao et al., 2023</xref>; <xref ref-type="bibr" rid="B102">Pang et al., 2023</xref>).</p>
</sec>
<sec id="S2.SS1.SSS4">
<title>2.1.4 Focal adhesion structure</title>
<p>Whether <italic>M. pneumoniae</italic> utilizes the terminal organelle or surface-associated glycolytic enzymes for adhesion, integrins on the host cell membrane play a central role in mediating this interaction. When <italic>M. pneumoniae</italic> adhesins engage with integrins, they initiate the assembly of &#x201C;focal adhesion&#x201D; (FA) complexes. FA anchors to intracellular actin filaments through adaptor proteins such as talin, vinculin, and paxillin, establishing a stable adhesion interface (<xref ref-type="bibr" rid="B53">Kanchanawong and Calderwood, 2023</xref>; <xref ref-type="bibr" rid="B84">Matrullo et al., 2025</xref>). This integrin-mediated FA structure has been demonstrated to be critical for static adhesion during host-pathogen interactions (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="bibr" rid="B50">Jones et al., 2019</xref>; <xref ref-type="bibr" rid="B52">Kamranvar et al., 2022</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p><italic>M. pneumoniae</italic> employs specialized adherence organelles and glycolytic enzymes to establish adhesion to respiratory epithelial cells. Notably, distinct glycolytic enzymes mediate host cell attachment by interacting with different ECM proteins, as indicated by dashed lines in the schematic representation (<xref ref-type="bibr" rid="B29">Grundel et al., 2016</xref>). When adhering to integrins, the pathogen forms an FA-like structure. This structure achieves mechanical stability through adaptor proteins, including talin, vinculin, and paxillin, which anchor the adhesion complex to intracellular actin filaments, creating a robust host-pathogen interface.</p></caption>
<alt-text>Diagram illustrating the interaction between Mycoplasma pneumoniae and human cell membranes. Elements include terminal organelles, integrins, and various proteins such as vinculin and talin. The image details processes occurring at the epithelium and basement membranes, highlighting connections with extracellular matrix components like fibronectin. Additionally, it shows intracellular components, glycoproteins, and structures like protein channels and phospholipids in the cell membrane, emphasizing the involvement of enzymes and pathways in bacterial adherence and infection.</alt-text>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1613760-g002.tif"/>
</fig>
</sec>
</sec>
<sec id="S2.SS2">
<title>2.2 Gliding motility based on the adhesion mechanism</title>
<p>The absence of a cell wall in <italic>M. pneumoniae</italic> facilitates its evolution of a unique translocation mechanism known as gliding motility (<xref ref-type="bibr" rid="B94">Miyata and Hamaguchi, 2016</xref>). Both adhesion and gliding can occur on the mucus layer and ciliated epithelial cells. Confocal microscopy studies using normal human bronchial epithelial (NHBE) cells have demonstrated that once <italic>M. pneumoniae</italic> traverses the mucus layer, it is capable of gliding along the cilia, migrating toward their base, and ultimately reaching the host cell surface (<xref ref-type="bibr" rid="B107">Prince et al., 2014</xref>).</p>
<p>The terminal organelle of <italic>M. pneumoniae</italic> interacts with SOS on the host cell surface to form a gliding fulcrum (<xref ref-type="bibr" rid="B62">Kawamoto et al., 2016</xref>). The pathogenic role of P1 in <italic>M. pneumoniae</italic> is thought to stem primarily from its function in mediating static adhesion during gliding. Specifically, the P1 adhesin binds to SOS on the host cell surface via a catch-pull-release mechanism, which is coordinated with the repeated extension and contraction of the terminal organelle to generate directional gliding. Additionally, the paired plates within the terminal organelle are essential for motility. They facilitate elongation and contraction of the organelle through structural remodeling in the distal region of the thick plate. During extension of the terminal organelle, the P1 adhesin detaches from SOS, whereas during contraction, it rebinds tightly (<xref ref-type="bibr" rid="B62">Kawamoto et al., 2016</xref>). Thus, gliding is achieved through iterative cycles of binding and release (<xref ref-type="fig" rid="F3">Figure 3A</xref>). After the use of monoclonal antibodies against P1 adhesin, the gliding speed decreased over time, and gliding cells were eventually removed from the glass surface (<xref ref-type="bibr" rid="B115">Seto et al., 2005</xref>). Emerging evidence suggests that the P30 protein in <italic>M. pneumoniae</italic> may function as a rotational-to-linear mechanotransducer, functionally analogous to the Gli521 &#x201C;crank&#x201D; protein in <italic>Mycoplasma mobile</italic> (<italic>M. mobile</italic>). This proposed mechanism involves the conversion of ATP hydrolysis-driven rotational torque into directional movement through coordinated interactions with the P1 adhesin, which is proposed to function as a homolog of the Gli349 &#x201C;leg protein&#x201D; in <italic>M. mobile&#x2019;s</italic> gliding apparatus (<xref ref-type="fig" rid="F3">Figure 3B</xref>; <xref ref-type="bibr" rid="B129">Toyonaga et al., 2021</xref>; <xref ref-type="bibr" rid="B148">Zuo et al., 2024</xref>). From the host&#x2019;s perspective, during <italic>M. pneumoniae</italic> adhesion to integrin receptors, the host cell initiates a mechanotransduction cascade: myosin generates tension, triggering the retrograde flow of actin filaments and the disassembly of focal adhesions. This coordinated cytoskeletal remodeling creates a propulsive substrate deformation wave, enabling directional gliding of the pathogen along the membrane plane through force-coupled membrane lipid redistribution. Force conduction throughout the entire process is directly completed by the talin protein and indirectly by the vinculin and paxillin proteins (<xref ref-type="fig" rid="F3">Figure 3C</xref>; <xref ref-type="bibr" rid="B84">Matrullo et al., 2025</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p><bold>(A)</bold> The gliding mechanism of <italic>M. pneumoniae</italic>. P1 adhesin binds to the host cell surface through a catch-pull-release cycle with SOS. During the terminal organelle&#x2019;s extension, P1 retracts from SOS, and during contraction, P1 binds to SOS tightly, while the iterative extension and retraction of the terminal organelle generate gliding movement. <bold>(B)</bold> The P1 and P30 proteins of <italic>M. pneumoniae</italic> may exhibit functional homology to the Gli349 and Gli521 adhesins in <italic>M. mobile</italic>, suggesting conserved molecular mechanisms underlying mycoplasma motility. <bold>(C)</bold> From the host&#x2019;s perspective, when the integrin binds to the substrate, myosin generates force, actin contracts, and the substrate detaches, thereby promoting the sliding of <italic>M. pneumoniae</italic> on the cell membrane. <bold>(D)</bold> The internal force direction of the core structure. The terminal organelle forces originate in the bowl complex, travel through MPN387 to the paired plates, and then lead to extension and retraction of the terminal organelle. <bold>(E)</bold> PrkC promotes the phosphorylation of HMW1 and HMW2 proteins to enhance <italic>M. pneumoniae</italic> gliding motility, whereas PrpC functions opposite manner.</p></caption>
<alt-text>&#x201C;A scientific illustration with five panels labeled A to E. - Panel A: Shows the mechanism involving P30 and P1 proteins interacting with a membrane during various stages. - Panel B: Depicts interactions of Mycoplasma mobile and Mycoplasma pneumoniae with epithelial membranes. - Panel C: Illustrates actin and talin interaction with extracellular matrix (ECM) components across a membrane. - Panel D: Shows a structure labeled MPN378 with a directional arrow. - Panel E: Describes a process with high molecular weight (HMW) proteins interacting with ADP, ATP, and Prkc, Prpc enzymes. Each panel provides insight into cellular and molecular interactions.&#x201D;</alt-text>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1613760-g003.tif"/>
</fig>
<p>The internal core of the terminal organelle is essential for maintaining gliding motility in <italic>M. pneumoniae</italic>. Earlier studies have shown that P200, MPN387, and TopJ proteins around the organelle base are more related to gliding than binding (<xref ref-type="bibr" rid="B34">Hasselbring et al., 2005</xref>; <xref ref-type="bibr" rid="B105">Pich et al., 2006</xref>; <xref ref-type="bibr" rid="B51">Jordan et al., 2007</xref>; <xref ref-type="bibr" rid="B95">Nakane et al., 2015</xref>). Thus, it is currently believed that the mechanical forces driving the terminal organelle originate from the bowl complex, travel through MPN387 to the paired plates, and subsequently lead to extension and retraction of the terminal organelle, finally causing P1 to attach to the internal core to undergo a corresponding catch-pull-release cycle (<xref ref-type="fig" rid="F3">Figure 3D</xref>; <xref ref-type="bibr" rid="B95">Nakane et al., 2015</xref>; <xref ref-type="bibr" rid="B61">Kawakita et al., 2016</xref>; <xref ref-type="bibr" rid="B62">Kawamoto et al., 2016</xref>). In terms of the research above, the effective transmission of internal force plays a pivotal role in <italic>M. pneumoniae</italic> adhesion and gliding motility. Phosphoprotein staining has confirmed a correlation between the phosphorylation of cytoskeletal proteins HMW1 and HMW2 and gliding activity. Since HMW1 and HMW2 are phosphorylated in an ATP-dependent manner by Ser/Thr kinases, the gliding characteristic can be partially controlled by reversing Ser/Thr phosphorylation, thereby affecting gliding frequency. The Ser/Thr protein kinase PrkC (MPN248) and its cognate phosphatase PrpC (MPN247) exert opposing effects on the gliding frequency of <italic>M. pneumoniae</italic>. PrkC acts as a phosphokinase, promoting the phosphorylation of HMW1 and HMW2 proteins to enhance motility; however, PrpC acts antagonistically by dephosphorylating these proteins, thereby reducing gliding activity (<xref ref-type="fig" rid="F3">Figure 3E</xref>; <xref ref-type="bibr" rid="B101">Page and Krause, 2013</xref>).</p>
</sec>
<sec id="S2.SS3">
<title>2.3 Comparative analysis of adhesion mechanisms between <italic>M. pneumoniae</italic> and <italic>M. genitalium</italic></title>
<p>To better elucidate the adhesion-related pathogenic mechanisms of <italic>M. pneumoniae</italic>, the adhesion mechanisms of <italic>Mycoplasma genitalium</italic> (<italic>M. genitalium</italic>), another phylogenetically related member of the Mollicutes class that possesses highly conserved adhesion strategies, were referred to and investigated. Similar to <italic>M. pneumoniae</italic>, <italic>M. genitalium</italic> utilizes a terminal organelle for adhesion, with core adhesins being P140 (MgPa) and P110 (MgPc) proteins (<xref ref-type="bibr" rid="B22">Deng et al., 2018</xref>). MgPa, the major adhesin, has been shown to bind to host molecules such as cyclosporin A (CypA) and histone H2B (<xref ref-type="bibr" rid="B75">Liao et al., 2021</xref>; <xref ref-type="bibr" rid="B72">Li et al., 2020</xref>). P32, a protein homologous to the P30 adhesin of <italic>M. pneumoniae</italic>, is essential for maintaining the stability of both MgPa and MgPc (<xref ref-type="bibr" rid="B143">Yueyue et al., 2022</xref>). Additionally, several accessory proteins, such as MG218, MG317, MG312, and P69, have been implicated in facilitating the adhesion process (<xref ref-type="bibr" rid="B143">Yueyue et al., 2022</xref>). <italic>M. genitalium</italic> also exhibits gliding motility, although its mechanism remains less well characterized than that of <italic>M. pneumoniae</italic>. Several adhesion-associated proteins, including MG218, MG317, and MG312, are involved in the gliding process, and gliding-specific proteins such as MG200 and MG386 are also indirectly linked to adhesion (<xref ref-type="bibr" rid="B143">Yueyue et al., 2022</xref>). Furthermore, CD14, a human receptor, recognizes lipid-associated membrane proteins (LAMPs) from <italic>M. genitalium</italic>, enhancing the release of TNF-&#x03B1; and intensifying the host inflammatory response (<xref ref-type="bibr" rid="B38">He et al., 2014</xref>).</p>
<p>Taken together, <italic>M. genitalium</italic> and <italic>M. pneumoniae</italic> share highly similar adhesion strategies, involving terminal organelles, coordinated binding-gliding dynamics, and downstream inflammatory cascades. Interestingly, while <italic>M. genitalium</italic> is typically associated with chronic urogenital infections, <italic>M. pneumoniae</italic> is more commonly linked to acute respiratory infections. Following adhesion, <italic>M. genitalium</italic> invades urogenital epithelial cells and can persist intracellularly for extended periods, promoting chronic infection. Antigenic variation of key adhesins such as MgPa and MgPc enhances immune evasion, further contributing to its ability to establish long-term colonization (<xref ref-type="bibr" rid="B85">McGowin and Totten, 2017</xref>; <xref ref-type="bibr" rid="B143">Yueyue et al., 2022</xref>). Investigating how <italic>M. genitalium</italic> utilizes adhesion to sustain persistent infection may provide critical insights into potential &#x201C;stealth survival&#x201D; strategies employed by <italic>M. pneumoniae</italic> within the respiratory tract.</p>
</sec>
<sec id="S2.SS4">
<title>2.4 Brief summary of adhesion and gliding mechanisms</title>
<p><italic>M. pneumoniae</italic> adhesion is primarily mediated by the terminal organelle and associated adhesins, notably P1, through a &#x201C;lock-and-key&#x201D; interaction with SOS on the host cell surface. Adhesion-related proteins interact with host components to form FA complexes that further stabilize the attachment. Gliding motility, which is closely tied to adhesion, also utilizes the terminal organelle as a pivot point. P1 plays a critical role in this process by facilitating movement through a coordinated grab&#x2013;pull&#x2013;release mechanism, synchronized with the extension and retraction of the organelle. Together, adhesion and gliding on host surfaces represent essential steps in the pathogenic process of <italic>M. pneumoniae</italic>.</p>
</sec>
</sec>
<sec id="S3">
<title>3 Adhesion-related mechanisms in intrapulmonary infection</title>
<sec id="S3.SS1">
<title>3.1 Toxicity pathogenic mechanisms related to adhesion</title>
<p><xref ref-type="bibr" rid="B133">Waites et al. (2017)</xref> demonstrated that <italic>M. pneumoniae</italic> adheres to epithelial cell surfaces to acquire essential nutrients while simultaneously releasing cytotoxic molecules that contribute to host cell damage. Upon adhesion, the pathogen extends microtubule-based structures into host cells, promoting metabolic exploitation by consuming oxygen, depleting glucose, absorbing cholesterol, and acquiring amino acids. These activities collectively lead to the accumulation of toxic metabolites and subsequent cellular injury (<xref ref-type="bibr" rid="B113">Schomburg and Vogel, 2012</xref>; <xref ref-type="bibr" rid="B27">Grosshennig et al., 2013</xref>; <xref ref-type="bibr" rid="B69">Kumar, 2018</xref>). Nevertheless, the precise molecular mechanisms underlying post-adhesion cytotoxicity and systemic tissue damage remain to be fully elucidated.</p>
<sec id="S3.SS1.SSS1">
<title>3.1.1 Hydrogen peroxide</title>
<p>The adhesion of <italic>M. pneumoniae</italic> to host cells initiates a cascade of events critical for bacterial survival and persistence. A key pathogenic strategy involves the production of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), which induces cytoskeletal reorganization by modulating effector proteins. This process depletes host nutrients and elevates cellular oxygen demand. Importantly, <italic>M. pneumoniae</italic> undergoes metabolic adaptation by utilizing host-derived glycerol as a carbon and energy source. Enhanced aerobic respiration leads to the accumulation of cytotoxic levels of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="B10">Blotz and Stulke, 2017</xref>). Cytoskeletal reorganization of host epithelial cells appears pivotal in producing cytotoxic substances and facilitating bacterial dissemination. Notably, the adhesion of <italic>M. pneumoniae</italic> not only triggers cytoskeletal rearrangement but also facilitates its translocation across the bronchial mucosal barrier. This process is accompanied by sustained H<sub>2</sub>O<sub>2</sub> release, leading to progressive pathological alterations in bronchial epithelial cells, including cellular edema, necrosis, intercellular adhesion, decelerated ciliary motility, and structural deformation (<xref ref-type="bibr" rid="B10">Blotz and Stulke, 2017</xref>). Although the precise mechanisms by which <italic>M. pneumoniae</italic> induces cytoskeletal remodeling remain incompletely defined, current evidence indicates that FA-mediated mechanotransduction plays a pivotal role. Specifically, pathogen adhesion activates focal adhesion kinase (FAK) and Src family kinases (<xref ref-type="bibr" rid="B84">Matrullo et al., 2025</xref>), which subsequently initiate Rho GTPase signaling cascades that drive cytoskeletal reorganization (<xref ref-type="bibr" rid="B9">Bement et al., 2024</xref>). Recent findings further suggest that force transmission from FAs to the cytoskeleton may represent the proximal mechanical signaling event initiating these structural changes. Notably, such mechanochemical coupling appears transient, potentially explaining the dynamic nature of cytoskeletal rearrangement during infection (<xref ref-type="bibr" rid="B9">Bement et al., 2024</xref>; <xref ref-type="bibr" rid="B84">Matrullo et al., 2025</xref>).</p>
<p>In this context, Glycerol-3-phosphate (G3P) serves as a critical carbon source at the adhesion site of <italic>M. pneumoniae</italic>. It is derived from free glycerol, which is transported into the cytoplasm via the glycerol facilitator (GlpF) and subsequently phosphorylated by glycerol kinase (GlpK). The lipoproteins MPN133 and MPN284 might also participate in the delivery of glycerol to GlpF. Additionally, glycerophosphodiesterase (GlpQ) converts glycerophosphocholine (GPC) into an alternative carbon source, which is imported via the recently identified transport protein GlpU (MPN421) (<xref ref-type="bibr" rid="B32">Halbedel et al., 2007</xref>; <xref ref-type="bibr" rid="B27">Grosshennig et al., 2013</xref>). The metabolism of G3P by glycerol-3-phosphate oxidase (GlpD) produces H<sub>2</sub>O<sub>2</sub>, which benefits bacterial survival but harms the host (<xref ref-type="bibr" rid="B112">Schmidl et al., 2011</xref>; <xref ref-type="bibr" rid="B27">Grosshennig et al., 2013</xref>).</p>
<p>As a virulence factor, H<sub>2</sub>O<sub>2</sub> plays a critical role in eliciting an oxidative stress response during <italic>M. pneumoniae</italic> infection. Due to the inadequacy of key antioxidant enzymes, such as superoxide dismutases and catalases, <italic>M. pneumoniae</italic> cannot effectively detoxify H<sub>2</sub>O<sub>2</sub>. As a major reactive oxygen species (ROS), pathologically accumulated H<sub>2</sub>O<sub>2</sub> induces cellular oxidative stress, damages biomacromolecules, disrupts energy metabolism, and activates inflammatory responses (<xref ref-type="bibr" rid="B103">Park, 2013</xref>). For <italic>M. pneumoniae</italic>, recent studies have shown that H<sub>2</sub>O<sub>2</sub> can accelerate the shedding of <italic>M. pneumoniae</italic>-infected cells. H<sub>2</sub>O<sub>2</sub>-induced oxidative DNA damage, including base oxidation and single- and double-strand breaks, triggers hyperactivation of poly (ADP-ribose) polymerase 1 (PARP1). This excessive DNA repair response depletes cellular nicotinamide adenine dinucleotide (NAD<sup>+</sup>) reserves, subsequently impairing mitochondrial ATP production. The ensuing bioenergetic collapse drives cells into a parthanatos death pathway, a PARP1-dependent programmed necrotic process characterized by irreversible metabolic failure (<xref ref-type="bibr" rid="B138">Yamamoto et al., 2019</xref>). ADP-ribosylation is a biochemical process in which the ADP-ribosyl group is transferred from NAD+ to specific amino acid residues on target proteins by ADP-ribosyl transferase (ADPRT). This reaction is catalyzed by several bacterial exotoxins, which disrupt macromolecular function and homeostasis (<xref ref-type="bibr" rid="B68">Krueger and Barbieri, 1995</xref>). Such disruptions facilitate the translocation of apoptosis-inducing factor (AIF) to the nucleus, ultimately resulting in apoptosis and cell death. Although the shedding of infected cells can reduce the infectivity of <italic>M. pneumoniae</italic> (<xref ref-type="bibr" rid="B76">Liesman et al., 2014</xref>), another study suggested that <italic>M. pneumoniae</italic> mitigates exogenous H<sub>2</sub>O<sub>2</sub>-induced shedding of infected epithelial cells by closely adhering to host cells and depleting cytosolic NAD<sup>+</sup>, which serves as the substrate for PARP1 activity (<xref ref-type="fig" rid="F4">Figure 4</xref>; <xref ref-type="bibr" rid="B138">Yamamoto et al., 2019</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>The adhesion-associated toxin mechanism of <italic>M. pneumoniae</italic>, including H<sub>2</sub>O<sub>2</sub> and CARDS TX.</p></caption>
<alt-text>Diagram illustrating the interaction between Mycoplasma pneumoniae and bronchial epithelium. Shows processes like glycerol metabolism, CARDS toxin release, and effects like cell death, ADP ribosylation, and vacuolation. Key molecules like GIPK, GIPQ, GIPU, GIPD, hydrogen peroxide, ATP, and various proteins are labeled, indicating biochemical pathways and cellular impacts such as cytoskeletal rearrangement and cell death through AIF and PARP1.</alt-text>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1613760-g004.tif"/>
</fig>
</sec>
<sec id="S3.SS1.SSS2">
<title>3.1.2 CARDS TX</title>
<p>The production and pathogenic activity of <italic>M. pneumoniae</italic> community-acquired respiratory distress syndrome toxin (CARDS TX) are mechanistically coupled with its adhesion process (<xref ref-type="bibr" rid="B57">Kannan et al., 2010</xref>). Substantial evidence reveals the coordinated upregulation of CARDS TX expression and key adhesins, with spatial colocalization observed at the terminal organelle. This functional synergy suggests that toxin deployment is spatially and temporally coordinated with host cell attachment, potentially amplifying cytotoxic effects through membrane-proximal action (<xref ref-type="bibr" rid="B57">Kannan et al., 2010</xref>; <xref ref-type="bibr" rid="B127">Techasaensiri et al., 2010</xref>). The expression of the CARDS TX gene, regulated by the mpn372 locus, serves dual functions as both a secreted cytotoxin and an adhesin. CARDS TX is a 591-amino-acid protein structurally divided into an N-terminal mART (D1 domain) and a C-terminal &#x03B2;-trefoil structure (D2 + D3 domain) (<xref ref-type="fig" rid="F5">Figure 5A</xref>; <xref ref-type="bibr" rid="B56">Kannan et al., 2014</xref>; <xref ref-type="bibr" rid="B8">Becker et al., 2015</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>The CARDS TX structure mapped by PyMoL with the main pathogenic mechanism. <bold>(A)</bold> The 3D protein structure of CARDS TX mapped by PyMOL. <bold>(B)</bold> The N-terminal Arg (R10), Asp (D12), Arg (R14), His (H36), and the mid-region Ser-Thr-Ser (S49-T50-S51) can bind with NAD<sup>+</sup> to facilitate ADP ribosylation. <bold>(C)</bold> The C-terminal (Y571-F591) is integral to proper D3 folding for facilitating vacuolation.</p></caption>
<alt-text>Molecular structure illustration showing domains D1, D2, and D3, with highlighted segments. Section A depicts a complex structure with colored markers indicating specific sites. Panel B focuses on ADP ribosylation, detailing amino acids R14, D12, R1, S107, and H36. Panel C highlights a segment crucial for internalization, specifying amino acids Y571 to F591. Arrows denote the function of these regions.</alt-text>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1613760-g005.tif"/>
</fig>
<p>CARDS TX facilitates host cell invasion through a dual-targeting mechanism that engages both protein receptors and membrane lipids. Notably, it can bind to surfactant protein-A (SP-A) and annexin A2 on the host cell surface, thereby initiating clathrin-mediated endocytosis (<xref ref-type="bibr" rid="B55">Kannan and Baseman, 2006</xref>). Furthermore, the C-terminal domains selectively interact with phosphatidylcholine (PC) and sphingomyelin (SM), lipid components enriched in membrane microdomains, thereby stabilizing bacterial adhesion and promoting toxin internalization (<xref ref-type="bibr" rid="B8">Becker et al., 2015</xref>). This coordinated engagement of receptors and lipids facilitates close bacterial-host interactions, enabling the localized delivery of CARDS TX at membrane interfaces and ultimately inducing cytotoxic effects (<xref ref-type="bibr" rid="B55">Kannan and Baseman, 2006</xref>; <xref ref-type="bibr" rid="B37">He et al., 2016</xref>).</p>
<p>As a virulence factor, <italic>M. pneumoniae</italic> exhibits both ADPRT and vacuolating activities. Key residues in the N-terminal (R10, D12, R14, H36) and mid-region (S49-T50-S51) bind NAD+ are critical for ADP ribosylation (<xref ref-type="fig" rid="F5">Figure 5B</xref>; <xref ref-type="bibr" rid="B67">Krishnan et al., 2013</xref>; <xref ref-type="bibr" rid="B56">Kannan et al., 2014</xref>; <xref ref-type="bibr" rid="B8">Becker et al., 2015</xref>). As described above, this ADP ribosylation disrupts cell function (<xref ref-type="bibr" rid="B56">Kannan et al., 2014</xref>; <xref ref-type="bibr" rid="B121">Somarajan et al., 2014</xref>), leading to cytopathic effects (CPE) and eventual cell death (<xref ref-type="fig" rid="F4">Figure 4</xref>; <xref ref-type="bibr" rid="B68">Krueger and Barbieri, 1995</xref>). The C-terminal region (Y571-F591) of CARDS TX mediates the binding of the toxin to the mammalian cell surface and induces subsequent endocytosis (<xref ref-type="fig" rid="F5">Figure 5C</xref>; <xref ref-type="bibr" rid="B67">Krishnan et al., 2013</xref>; <xref ref-type="bibr" rid="B56">Kannan et al., 2014</xref>; <xref ref-type="bibr" rid="B8">Becker et al., 2015</xref>). Similar to the purified vacuolating cytotoxin (VacA) protein of H. pylori, internalization is essential for its vacuolation activity. CARDS TX-induced vacuoles are enriched with Rab9 GTPase, which mediates vacuole formation via the Golgi membrane (<xref ref-type="bibr" rid="B49">Johnson et al., 2011</xref>). While the vacuolation mechanism in <italic>M. pneumoniae</italic> remains unclear (<xref ref-type="bibr" rid="B55">Kannan and Baseman, 2006</xref>; <xref ref-type="bibr" rid="B56">Kannan et al., 2014</xref>; <xref ref-type="bibr" rid="B121">Somarajan et al., 2014</xref>; <xref ref-type="bibr" rid="B8">Becker et al., 2015</xref>), studies have highlighted similarities between CARDS TX and H. pylori VacA toxins (<xref ref-type="table" rid="T2">Table 2</xref>, <xref ref-type="fig" rid="F4">Figure 4</xref>; <xref ref-type="bibr" rid="B3">Ansari and Yamaoka, 2020</xref>).</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>The similarity between CARDS TX and <italic>H. pylori</italic> VacA toxins in terms of vacuolation.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Toxins</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Protein structure</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Receptors related to the internalization</td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Vacuolation</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">CARDS TX</td>
<td valign="top" align="left">Folded into three regions by 17&#x03B1; and 43&#x03B2; helices, it contains an N-terminal mART (D1 domain) and a C-terminal &#x03B2;-trefoil structure (D2 + D3 domain) in series.</td>
<td valign="top" align="left">SP-A, A2 protein, PC, SM</td>
<td valign="top" align="left">Rab9 enrichment occurred around the CARDS TX-induced vacuoles, and Rab9 was involved in vacuole formation through the Golgi membrane.</td>
</tr>
<tr>
<td valign="top" align="left">VacA toxins</td>
<td valign="top" align="left">An N-terminal p33 domain and a C-terminal p55 domain, linked by a flexible loop that is sensitive to limited proteolysis <italic>in vitro</italic>.</td>
<td valign="top" align="left">Tyrosine phosphatases (PRTP&#x03B1; and PRTP&#x03B2;), lipoprotein receptor-related protein-1 (LRP1)</td>
<td valign="top" align="left">VacA is involved in the synthesis of large bacteria containing vacuoles in infected cells, caused by the fusion of late endocytic compartments.</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
</sec>
<sec id="S3.SS2">
<title>3.2 The immune pathogenic mechanisms related to adhesion</title>
<sec id="S3.SS2.SSS1">
<title>3.2.1 Inflammatory reaction related to adhesion</title>
<p>The adhesion ability of <italic>M. pneumoniae</italic> appears to be a prerequisite for activating the immune response during infection. <xref ref-type="bibr" rid="B13">Chaudhry et al. (2005)</xref> identified immunodominant regions in the C-terminus of P1 protein (residues 1,125&#x2013;1,131 and 1,382&#x2013;1,394) that trigger an immune response once the protein attaches to the mucosal surface. <xref ref-type="bibr" rid="B41">Hoek et al. (2005)</xref> demonstrated that adherent <italic>M. pneumoniae</italic> induces IL-4 production in murine basophils, whereas non-adherent strains fail to elicit significant cytokine responses. This disparity is primarily attributed to the higher abundance of P1 protein in adherent <italic>M. pneumoniae</italic>. Similarly, <xref ref-type="bibr" rid="B118">Shimizu et al. (2011)</xref> found that the wild-type strain of <italic>M. pneumoniae</italic> stimulates the production of inflammatory cytokines, including IL-1&#x03B2; and tumor necrosis factor-&#x03B1; (TNF-&#x03B1;). In contrast, a mutant strain lacking adhesion ability failed to induce cytokine production.</p>
<p>Besides, <italic>M. pneumoniae</italic> adheres to the host airway through LAMP, whose lipid portion is recognized by Toll-like receptor (TLR) complexes predominantly expressed on respiratory epithelial cells and immune cells (<xref ref-type="bibr" rid="B79">Malik et al., 2023</xref>), activating cellular signal transduction pathways (<xref ref-type="bibr" rid="B147">Zuo et al., 2009</xref>). Following adhesion, <italic>M. pneumoniae</italic> interacts with TLR4 to induce macrophage autophagy, enhancing the synthesis and secretion of pro-inflammatory cytokines, including IL-1&#x03B2;, IL-6, and IL-8 (<xref ref-type="bibr" rid="B119">Shimizu et al., 2014</xref>). Furthermore, the recognition of LAMP by TLRs triggers an inflammatory response characterized by lymphocyte, neutrophil, and occasionally eosinophil infiltration, promoting IL-1&#x03B2;, IL-6, IL-8, and TNF-&#x03B1;, as well as inflammatory mediators like ROS (<xref ref-type="bibr" rid="B45">Into et al., 2007</xref>; <xref ref-type="bibr" rid="B116">Shimizu et al., 2007</xref>, <xref ref-type="bibr" rid="B117">2008</xref>; <xref ref-type="bibr" rid="B39">He et al., 2009</xref>).</p>
</sec>
<sec id="S3.SS2.SSS2">
<title>3.2.2 Immune escape related to adhesion</title>
<p>Although adhesion supports the survival of <italic>M. pneumoniae</italic> in the host, the immune response it triggers acts as a barrier to pathogenic progression. To counter this, <italic>M. pneumoniae</italic> adhesion proteins employ various immune evasion strategies to mitigate host defenses (<xref ref-type="bibr" rid="B23">Ferreira et al., 2006</xref>; <xref ref-type="bibr" rid="B120">Sluijter et al., 2009</xref>; <xref ref-type="bibr" rid="B111">Schmidl et al., 2010</xref>; <xref ref-type="bibr" rid="B142">Yu et al., 2020</xref>). After adhesion to epithelial cells, the adhesins of <italic>M. pneumoniae</italic> are phosphorylated by protein kinase PrkC, producing multiple phosphorylated forms that aid in immune evasion (<xref ref-type="bibr" rid="B111">Schmidl et al., 2010</xref>; <xref ref-type="bibr" rid="B134">Widjaja et al., 2020</xref>). <xref ref-type="bibr" rid="B120">Sluijter et al. (2009)</xref> demonstrated that the RecA protein homolog encoded by mpn490 promotes gene exchange between homologous DNA sequences (mainly RepMP) in <italic>M. pneumoniae</italic>, leading to variations in surface adhesins and facilitating immune evasion. Another study revealed that abundant complement factor H is expressed at the site of <italic>M. pneumoniae</italic> colonization, which strengthens adherence between mycoplasmas and tracheal epithelial cells. Moreover, <italic>M. pneumoniae</italic> can bind factor H through specific binding proteins, such as EF-Tu, PDH-B, and PDH-A, thereby mimicking host cells to regulate complement activation and evade immune responses (<xref ref-type="bibr" rid="B23">Ferreira et al., 2006</xref>; <xref ref-type="bibr" rid="B142">Yu et al., 2020</xref>).</p>
</sec>
</sec>
</sec>
<sec id="S4">
<title>4 Adhesion-related mechanisms in extrapulmonary infection</title>
<sec id="S4.SS1">
<title>4.1 Direct adhesion-related pathogenic mechanism</title>
<p><italic>M. pneumoniae</italic> infection also causes a wide range of extrapulmonary diseases involving multiple systems, including cutaneous, musculoskeletal, neurological, hematological, digestive, and renal systems (<xref ref-type="bibr" rid="B43">Hu et al., 2022</xref>). Direct adhesion has also been identified as a critical factor driving pathogen-host interactions, playing a significant role in the extrapulmonary pathogenesis. Beyond its well-established ability to bind respiratory epithelial cells, <italic>in vitro</italic> studies have also demonstrated that <italic>M. pneumoniae</italic> can adhere to macrophages and erythrocytes (<xref ref-type="bibr" rid="B12">Chaudhry et al., 2016</xref>; <xref ref-type="bibr" rid="B106">Poddighe, 2018</xref>). Notably, when colonizing respiratory surfaces with compromised epithelial integrity, particularly within immunologically immature or damaged mucosal barriers, the pathogen may exploit these adhesion sites and gain access to the systemic circulation through structural breaches in the epithelial layer (<xref ref-type="bibr" rid="B15">Choi et al., 2017</xref>). <italic>M. pneumoniae</italic> exhibits hemolytic activity through adhesion to erythrocyte membranes, mediated by interactions between bacterial surface proteins and SOS on red blood cells. These interactions alter erythrocyte surface antigens, promoting neo-antigen formation and molecular mimicry, which ultimately elicit complement-mediated autoimmune hemolysis (<xref ref-type="bibr" rid="B21">de Groot et al., 2017</xref>). <italic>M. pneumoniae</italic> adhesion to erythrocytes may further contribute to its extrapulmonary dissemination. Its successful isolation from pericardial effusion and cerebrospinal fluid provides clinical evidence supporting its capacity for direct tissue invasion (<xref ref-type="bibr" rid="B98">Neimark and Gesner, 2010</xref>). In addition, emerging clinical reports describe <italic>M. pneumoniae</italic>-associated hepatitis occurring before respiratory symptoms, suggesting a hepatotropic pathogenesis potentially mediated by direct bacterial adhesion to hepatic cells, although further evidence is required (<xref ref-type="fig" rid="F6">Figure 6</xref>; <xref ref-type="bibr" rid="B97">Narita, 2016</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>The adhesion-related mechanisms of <italic>M. pneumoniae</italic> in extrapulmonary infection.</p></caption>
<alt-text>Diagram showing the impact of Mycoplasma pneumoniae on the respiratory epithelium and bloodstream. The bacteria damage the epithelium and enter erythrocytes, indicating direct damage and molecular mimicry. Effects spread to the heart, brain, liver, and skin, highlighting systemic impact.</alt-text>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-16-1613760-g006.tif"/>
</fig>
</sec>
<sec id="S4.SS2">
<title>4.2 Indirect adhesion-related pathogenic mechanism</title>
<p>Current research remains limited in elucidating the extrapulmonary pathogenic mechanisms of <italic>M. pneumoniae</italic>, while molecular simulation approaches may offer new insights. Adhesion proteins localized at the <italic>M. pneumoniae</italic> terminal organelle, such as P1 and P30, exhibit C-terminal homology with host troponin and cytoskeletal proteins. This molecular mimicry enables cross-reactive antibodies against bacterial adhesins to bind host cytoskeletal components, thereby amplifying autoimmune responses (<xref ref-type="bibr" rid="B18">Dallo et al., 1990</xref>; <xref ref-type="bibr" rid="B96">Narita, 2010</xref>; <xref ref-type="bibr" rid="B37">He et al., 2016</xref>). Neurological manifestations represent one of the most prevalent extrapulmonary complications of <italic>M. pneumoniae</italic> infection. The pathogen&#x2019;s P1 adhesin binds to membrane glycolipids to form galactocerebroside C (GalC)-like complexes, establishing structural homology with human myelin components. This molecular mimicry mechanism triggers the production of cross-reactive antibodies that mistakenly target myelin-associated glycolipids, such as GalC and gangliosides, leading to autoimmune-mediated demyelination. This mechanism underlies <italic>M. pneumoniae</italic>-associated encephalitis and Guillain-Barr&#x00E9; syndrome (<xref ref-type="bibr" rid="B89">Meyer Sauteur et al., 2014a</xref>). Meanwhile, the molecular mimicry between the P1 adhesin of <italic>M. pneumoniae</italic> and keratinocyte antigens can induce the production of cross-reactive antibodies, formation of immune complexes, and complement activation, which collectively contribute to the development of Mycoplasma-induced rash and mucositis (MIRM) (<xref ref-type="fig" rid="F6">Figure 6</xref>; <xref ref-type="bibr" rid="B12">Chaudhry et al., 2016</xref>).</p>
</sec>
</sec>
<sec id="S5">
<title>5 The adhesion-related characteristics during <italic>M. pneumoniae</italic> asymptomatic carriage</title>
<p>Studies have shown that asymptomatic carriage of <italic>M. pneumoniae</italic> in the upper respiratory tract (URT) is common across all pediatric age groups. This high carriage rate complicates the diagnosis of <italic>M. pneumoniae</italic> infection, as the clinical symptoms and signs of respiratory tract infection are not specific and reliably predictive (<xref ref-type="bibr" rid="B124">Spuesens et al., 2013</xref>). Moreover, neither serological testing nor polymerase chain reaction (PCR) can reliably distinguish active infection from asymptomatic carriage, creating significant challenges for clinicians in determining whether and when to initiate antimicrobial therapy (<xref ref-type="bibr" rid="B125">Spuesens et al., 2014</xref>; <xref ref-type="bibr" rid="B91">Meyer Sauteur et al., 2016</xref>). In addition to diagnostic and therapeutic challenges, asymptomatic carriers of <italic>M. pneumoniae</italic> represent an important source of transmission. The carriage state has the potential to transition into symptomatic infection and can exacerbate pre-existing pulmonary conditions such as asthma, warranting heightened clinical attention (<xref ref-type="bibr" rid="B124">Spuesens et al., 2013</xref>; <xref ref-type="bibr" rid="B65">Koenen et al., 2023</xref>).</p>
<p>Considering the previously described adhesion pathogenesis, it is important to explore how the host maintains an asymptomatic carriage state for extended periods following initial colonization via bacterial adhesins. <xref ref-type="bibr" rid="B20">de Groot et al. (2022)</xref> reported that during asymptomatic carriage of <italic>M. pneumoniae</italic>, mucosal antibodies (IgG and IgA) targeting key adhesins of the bacterial attachment organelle, including P1, P30, and P116, are largely undetectable in the URT. This deficiency of specific mucosal antibodies may impair the host&#x2019;s defense mechanisms against bacterial adhesion, as these immunoglobulins are typically involved in neutralizing adhesion-mediated interactions with epithelial surfaces. Consequently, persistent adherence facilitates long-term colonization and establishes an immunological niche that supports prolonged asymptomatic carriage. The failure to mount an effective mucosal antibody response may be attributed to the limited expansion and activation capacity of local B cells in the URT (<xref ref-type="bibr" rid="B88">Meyer Sauteur et al., 2018</xref>). In parallel, recent studies have demonstrated that asymptomatic carriage is associated with a marked reduction in URT microbiota diversity and an increased abundance of Haemophilus influenzae (<xref ref-type="bibr" rid="B65">Koenen et al., 2023</xref>). Such microbial dysbiosis, or the lack of normal microbial competition, may facilitate <italic>M. pneumoniae</italic> colonization. It is also well-established that natural immunity following <italic>M. pneumoniae</italic> infection is typically short-lived. Upon initial adhesion, <italic>M. pneumoniae</italic> forms a &#x201C;firm but superficial&#x201D; attachment to the epithelial surface. If the transient and relatively mild immune response fails to eliminate the pathogen, the host may transition into a prolonged asymptomatic carriage state once this short-lived immunity wanes (<xref ref-type="bibr" rid="B133">Waites et al., 2017</xref>). Notably, asymptomatic carriage may evolve into a self-perpetuating cycle. Persistent bacterial adhesion results in the continuous release of metabolic by-products and the induction of low-grade inflammation, which progressively damages the mucociliary barrier of the respiratory tract. This epithelial disruption impairs mucosal clearance, thereby promoting continued colonization. In turn, sustained colonization exacerbates epithelial damage and promotes chronic airway inflammation (<xref ref-type="bibr" rid="B108">Prince et al., 2018</xref>). Collectively, these factors contribute to a dynamic equilibrium between the pathogen and host, sustaining bacterial persistence without eliciting overt pathological responses (<xref ref-type="bibr" rid="B92">Meyer Sauteur et al., 2014b</xref>).</p>
</sec>
<sec id="S6">
<title>6 Advances in treatment and prevention based on the adhesion theory</title>
<sec id="S6.SS1">
<title>6.1 Clinical significance of <italic>M. pneumoniae</italic> adhesion</title>
<p>Adhesion, as a key step in the pathogenic mechanism of <italic>M. pneumoniae</italic>, carries profound clinical significance. Without successful adhesion, the bacterium cannot initiate infection, as both direct cytotoxicity and immune activation are highly dependent on this process. To date, research on the clinical implications and patient outcomes related to <italic>M. pneumoniae</italic> adhesion has primarily focused on the P1 protein. Epidemiological studies have highly concentrated on P1 genotyping, which is based on sequence variation within the RepMP2/3 and RepMP4 repetitive elements. According to these variations, <italic>M. pneumoniae</italic> strains are broadly classified into P1-1 and P1-2 types (<xref ref-type="bibr" rid="B123">Spuesens et al., 2009</xref>; <xref ref-type="bibr" rid="B70">Lee et al., 2019</xref>). While the distribution of these P1 genotypes varies by geographic region and over time, current evidence suggests that P1 genotype alone does not reliably predict clinical outcomes, such as asymptomatic carriage, disease severity, or extrapulmonary manifestations (<xref ref-type="bibr" rid="B90">Meyer Sauteur et al., 2021</xref>). However, emerging data indicate that the P1-2 genotype is increasingly associated with high-level macrolide resistance and may exhibit a greater capacity for transmission compared to P1-1 strains (<xref ref-type="bibr" rid="B73">Li et al., 2022</xref>; <xref ref-type="bibr" rid="B71">Li et al., 2024</xref>). Therefore, continuous monitoring of P1 genotypes could offer valuable insights into antimicrobial susceptibility in pediatric populations and support more informed clinical decision-making. Additionally, advances in PCR-based denaturing gradient gel electrophoresis (DGGE) have significantly improved the sensitivity of detecting <italic>M. pneumoniae</italic> variants, which is potentially beneficial for patient prognosis and therapeutic outcomes (<xref ref-type="bibr" rid="B137">Xiao et al., 2014</xref>).</p>
</sec>
<sec id="S6.SS2">
<title>6.2 Current therapeutic strategies for <italic>M. pneumoniae</italic></title>
<p>Although macrolides remain the first-line therapy for MPP, recent surveillance data indicate a rapidly increasing prevalence of MRMP strains worldwide (Jiang J. C. et al., 2021). <italic>M. pneumoniae</italic> synthesizes polypeptides by forming peptide bonds at the peptidyl transferase center (PTC) of the 50S ribosomal subunit and exporting them through the nascent peptide exit tunnel (NPET)&#x2014;a critical step in bacterial protein synthesis. Previous studies have shown that macrolide antibiotics bind within the NPET, narrowing the tunnel&#x2019;s diameter, thereby obstructing peptide elongation and inhibiting the synthesis of all nascent proteins, which underlies their antibacterial activity (<xref ref-type="bibr" rid="B54">Kannan et al., 2012</xref>; <xref ref-type="bibr" rid="B77">Lin et al., 2018</xref>). However, mutations at nucleotide positions A2063G and A2064G in the 23S rRNA, along with alterations in ribosomal proteins L4 and L22, hinder macrolide binding to the ribosome, leading to loss of drug efficacy (<xref ref-type="bibr" rid="B104">Pereyre et al., 2016</xref>). Furthermore, the recent predominance of the P1-2 genotype has been linked to the growing dissemination of MRMP strains. This rising threat of antimicrobial resistance highlights the urgent need for novel therapeutic strategies. Although tetracyclines (e.g., doxycycline) and fluoroquinolones (e.g., levofloxacin) are potential alternatives, their use in pediatrics is strictly restricted due to class-specific toxicity profiles. Tetracyclines are contraindicated in children under 8 years of age due to risks of permanent dental discoloration and enamel hypoplasia, while fluoroquinolones are associated with black-box warnings for musculoskeletal side effects, including tendinopathy and cartilage damage, primarily through matrix metalloproteinase inhibition (<xref ref-type="bibr" rid="B124">Spuesens et al., 2013</xref>). For patients with rapidly progressing disease or those experiencing severe complications, adjunctive therapies such as corticosteroids and gamma globulin have been employed. However, these agents primarily serve to suppress inflammation and do not exert direct antimicrobial effects (<xref ref-type="bibr" rid="B25">Gao and Sun, 2024</xref>). Given these limitations, there is increasing interest in the development of novel therapeutics based on the adhesion mechanisms of <italic>M. pneumoniae</italic>. Since adhesion is a key step in the bacterium&#x2019;s pathogenesis, targeting this process may provide a promising alternative to conventional antimicrobial therapy and help overcome the challenges posed by macrolide resistance.</p>
</sec>
<sec id="S6.SS3">
<title>6.3 Treatment based on adhesion pathogenesis</title>
<p>In recent years, several compounds have been identified that effectively inhibit <italic>M. pneumoniae</italic> adhesion and show promising therapeutic potential. For example, Meng et al. reported that Platycodin D, a traditional Chinese medicine, significantly suppressed the expression of key adhesins P1 and P30. This led to bacterial detachment from respiratory epithelial cells, disrupted nutrient acquisition, and ultimately inhibited proliferation (<xref ref-type="bibr" rid="B86">Meng et al., 2017</xref>). Likewise, <xref ref-type="bibr" rid="B24">Galgowski et al. (2021)</xref> demonstrated that methanolic extract (ME) from Melipona quadrifasciata propolis, a stingless bee species endemic to Brazil, exhibits potent anti-adhesion activity against <italic>M. pneumoniae</italic>, underscoring the therapeutic promise of natural products in combating bacterial colonization. Besides, <xref ref-type="bibr" rid="B110">Reddy et al. (1996)</xref> evidenced that adhesins and adhesin-related accessory proteins of <italic>M. pneumoniae</italic> are proline-rich in composition and mediated successful adhesion to host target cells. Cyps facilitate bacterial adhesion by promoting the proper folding of proline-rich proteins involved in host cell attachment. However, their enzymatic activity can be selectively inhibited by cyclosporin A (CsA), thereby disrupting adhesion and offering a potential therapeutic strategy for MPP. Collectively, these findings highlight the potential of targeting <italic>M. pneumoniae</italic> adhesion pathways as an innovative approach to overcome the limitations of current therapies, particularly in light of increasing macrolide resistance.</p>
</sec>
<sec id="S6.SS4">
<title>6.4 Vaccine development based on adhesion pathogenesis</title>
<p>Since the discovery of <italic>M. pneumoniae</italic>, the development of effective vaccines has been a longstanding research focus; however, to date, no highly effective vaccine is available for the prevention of human <italic>M. pneumoniae</italic> infections (<xref ref-type="bibr" rid="B144">Zeng et al., 2025</xref>). Given the growing challenges posed by antimicrobial resistance and the limitations of current therapeutic strategies, there is an urgent need to develop a vaccine capable of protecting children from <italic>M. pneumoniae</italic> infections. Studies have shown that whole-cell inactivated vaccines exhibit limited efficacy, while live-attenuated vaccines raise significant safety concerns, both of which restrict their applicability in human populations (<xref ref-type="bibr" rid="B48">Jiang Z. et al., 2021</xref>). Consequently, attention has shifted toward subunit vaccine development, particularly focusing on adhesion-related proteins such as P1, P30, and P116, which have demonstrated strong immunogenicity and immunoreactivity (<xref ref-type="bibr" rid="B48">Jiang Z. et al., 2021</xref>). According to <xref ref-type="bibr" rid="B20">de Groot et al. (2022)</xref>, during <italic>M. pneumoniae</italic> infection, the upper respiratory tract produces mucosal IgA and IgG antibodies that specifically target the adhesins P1, P30, and P116. These antibodies may provide a basis for vaccine strategies aimed at blocking bacterial adhesion, thereby disrupting infection and transmission and ultimately helping to reduce the burden of disease in children. In support of this approach, <xref ref-type="bibr" rid="B114">Schurwanz et al. (2009)</xref> identified the C-terminal region of P1 [amino acids (aa) 1288&#x2013;1518] and the central region of P30 (aa 17&#x2013;274) as highly immunoreactive and critical for host cell adhesion. They further designed a chimeric protein combining these regions, which induced monospecific antiserum that significantly reduced <italic>M. pneumoniae</italic> adherence to human bronchial epithelial cells (<xref ref-type="bibr" rid="B114">Schurwanz et al., 2009</xref>; <xref ref-type="bibr" rid="B35">Hausner et al., 2013</xref>). Additional evidence suggests the potential of mRNA vaccine technology in this context. Zeng et al. demonstrated that anchoring the C-terminal domain of the P1 adhesin to an mRNA vaccine conferred partial protection against <italic>M. pneumoniae</italic> infection in animal models (<xref ref-type="bibr" rid="B144">Zeng et al., 2025</xref>). Similarly, Svenstrup et al. purified the P116 protein and observed that polyclonal antibodies targeting P116 effectively inhibited bacterial adhesion to HEp-2 cells, highlighting its value as a vaccine candidate (<xref ref-type="bibr" rid="B48">Jiang Z. et al., 2021</xref>). Therefore, all the antigens above have the potential to become antigenic candidates for vaccine research. In 2016, <xref ref-type="bibr" rid="B14">Chen et al. (2016)</xref> designed a chimeric protein (P116N-P1C-P30), named MP559, which contains multiple antigenic epitopes of the above three antigens. Vaccination with MP559 stimulated the same humoral immune response as vaccination with these three antigens alone. This study showed that MP559 has the potential to replace the three individual subunit vaccine candidate proteins. Despite the encouraging immunogenicity observed in animal models, none of these vaccine candidates have advanced to clinical trials. Their efficacy and safety in humans remain significant hurdles. Moreover, vaccine-enhanced disease (VED) has emerged as a critical concern in <italic>M. pneumoniae</italic> vaccine development. LAMP from <italic>M. pneumoniae</italic> has been implicated in exacerbating inflammatory responses. In animal studies, mice vaccinated with LAMP exhibited more severe inflammation and tissue pathology compared to controls, suggesting that careful consideration of LAMP components is necessary during vaccine formulation (<xref ref-type="bibr" rid="B80">Mara et al., 2020</xref>; <xref ref-type="bibr" rid="B81">Mara et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="S7" sec-type="conclusion">
<title>7 Conclusion</title>
<p>Adhesion-related pathogenesis plays a central role in <italic>M. pneumoniae</italic> infection. By attaching to respiratory epithelial cells through its specialized terminal organelle and various adhesion proteins, <italic>M. pneumoniae</italic> initiates its infectious process. The gliding motility further enhances bacterial colonization and spread. Once adhered, <italic>M. pneumoniae</italic> exploits host-derived nutrients and releases cytotoxic substances such as H<sub>2</sub>O<sub>2</sub> and CARDS TX, leading to host cell damage. In parallel, bacterial adhesion triggers robust inflammatory responses and facilitates immune evasion by masking surface antigens, thereby prolonging bacterial survival within the host. Notably, adhesion-mediated mechanisms are also implicated in extrapulmonary manifestations, contributing to the broad clinical spectrum of <italic>M. pneumoniae</italic> infection. Due to the core pathogenic mechanism of adhesion, some treatments and preventions of <italic>M. pneumoniae</italic> infections targeting adhesion are currently some of the research hotspots.</p>
<p>Despite these insights, key questions remain unanswered, particularly regarding the differences in adhesion dynamics between symptomatic infections and asymptomatic carriage. Understanding these distinctions is critical for developing targeted interventions.</p>
<p>Looking ahead, future research should aim to further clarify the molecular mechanisms of <italic>M. pneumoniae</italic> adhesion and gliding, identify therapeutic targets within host-pathogen interactions, and assess immune responses to adhesion disruption. Clinically, combining adhesion-targeted strategies with existing antibiotics may enhance treatment efficacy, reduce transmission, and help curb resistance. Adhesion-based vaccines targeting immunogenic regions of these proteins offer a promising approach to prevention, especially amid rising macrolide resistance. Continued research into adhesion mechanisms will be essential for developing more effective therapies and preventive measures across all age groups.</p>
</sec>
</body>
<back>
<sec id="S8" sec-type="author-contributions">
<title>Author contributions</title>
<p>BYS: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. YZL: Writing &#x2013; original draft. JHL: Writing &#x2013; original draft. LM: Writing &#x2013; original draft. ZGJ: Writing &#x2013; review &#x0026; editing. HBL: Writing &#x2013; review &#x0026; editing. YL: Writing &#x2013; review &#x0026; editing. GY: Writing &#x2013; review &#x0026; editing. MWW: Writing &#x2013; review &#x0026; editing. FM: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. MG: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="S9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Natural Science Foundation (Grant No. 20200201475JC), the Health Science and Technology Promotion Project of Jilin Province (Grant No. 2023LC010), and the Finance Department Medical Special Fund of Jilin Province (Grant No. 2018SCZWSZX-051).</p>
</sec>
<ack><p>We use Biorender to create our figures.</p>
</ack>
<sec id="S10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="S12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>CAP, community-acquired pneumonia; MRMP, macrolide-resistant <italic>M. pneumonia</italic>; H<sub>2</sub>O<sub>2</sub>, hydrogen peroxide; CARDS TX, Community-acquired respiratory distress syndrome toxin; Kbp, kilobase pairs; RNAP, RNA polymerase; NusA, N-utilizing substance A; URT, upper respiratory tract; MPP, <italic>M. pneumoniae</italic> Pneumonia; RMPP, refractory <italic>M. pneumoniae</italic> pneumonia; SOS, sialylated oligosaccharides; APR, acidic- and praline-rich region; LDH, lactate dehydrogenase; PGM, phosphoglycerate mutase; PYK, pyruvate kinase; GapA, glyceraldehyde-3-phosphate dehydrogenase; TKT, transketolase; PdhA-C, pyruvate dehydrogenase A-C ; ECM, extracellular matrix; EF-Tu, elongation factor Tu; Fn, fibronectin; Ln, laminin; Vn, vitronectin; FA, focal adhesion; LAMP, lipid-associated membrane proteins; NHBE, normal human bronchial epithelial; CypA, cyclosporin A; G3P, glycerol-3-phosphate; GlpF, glycerol facilitator; GlpK, glycerol kinase; GlpQ, glycerophosphodiesterase; GPC, glycerophosphocholine; GlpD, glycerol-3-phosphate oxidase; ROS, reactive oxygen species; PARP1, poly ADP-ribose polymerase family member 1; NAD + , nicotinamide adenine dinucleotide; ADPRT, ADP ribosyltransferase; AIF, apoptosis-inducing factor; SP-A, surfactant protein-A; PC, phosphatidylcholine; SM, sphingomyelin; CPE, cytopathic effects; VacA, vacuolating cytotoxin; TNF &#x2013; &#x03B1; , tumor necrosis factor- &#x03B1; ; TLR, Toll-like receptor complexes; GalC, galactocerebroside C; MIRM, Mycoplasma-induced rash and mucositis; RCR, polymerase chain reaction; DGGE, denaturing gradient gel electrophoresis; PTC, peptidyl transferase center; NPET, nascent peptide exit tunnel; ME, methanolic extract; CsA, cyclosporin A; VED, vaccine-enhanced disease.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aberg</surname> <given-names>A.</given-names></name> <name><surname>Gideonsson</surname> <given-names>P.</given-names></name> <name><surname>Bhat</surname> <given-names>A.</given-names></name> <name><surname>Ghosh</surname> <given-names>P.</given-names></name> <name><surname>Arnqvist</surname> <given-names>A.</given-names></name></person-group> (<year>2024</year>). <article-title>Molecular insights into the fine-tuning of pH-dependent ArsR-mediated regulation of the SabA adhesin in <italic>Helicobacter</italic> pylori.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>52</volume> <fpage>5572</fpage>&#x2013;<lpage>5595</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkae188</pub-id> <pub-id pub-id-type="pmid">38499492</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreae</surname> <given-names>C. A.</given-names></name> <name><surname>Sessions</surname> <given-names>R. B.</given-names></name> <name><surname>Virji</surname> <given-names>M.</given-names></name> <name><surname>Hill</surname> <given-names>D. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Bioinformatic analysis of meningococcal Msf and Opc to inform vaccine antigen design.</article-title> <source><italic>PLoS One</italic></source> <volume>13</volume>:<fpage>e0193940</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0193940</pub-id> <pub-id pub-id-type="pmid">29547646</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname> <given-names>S.</given-names></name> <name><surname>Yamaoka</surname> <given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Role of vacuolating cytotoxin A in <italic>Helicobacter</italic> pylori infection and its impact on gastric pathogenesis.</article-title> <source><italic>Expert. Rev. Anti. Infect. Ther.</italic></source> <volume>18</volume> <fpage>987</fpage>&#x2013;<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1080/14787210.2020.1782739</pub-id> <pub-id pub-id-type="pmid">32536287</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname> <given-names>S.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>2008</year>). <article-title>The surface-exposed carboxyl region of Mycoplasma pneumoniae elongation factor Tu interacts with fibronectin.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>76</volume> <fpage>3116</fpage>&#x2013;<lpage>3123</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00173-08</pub-id> <pub-id pub-id-type="pmid">18411296</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balish</surname> <given-names>M. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Mycoplasma pneumoniae, an underutilized model for bacterial cell biology.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>196</volume> <fpage>3675</fpage>&#x2013;<lpage>3682</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01865-14</pub-id> <pub-id pub-id-type="pmid">25157081</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balish</surname> <given-names>M. F.</given-names></name> <name><surname>Santurri</surname> <given-names>R. T.</given-names></name> <name><surname>Ricci</surname> <given-names>A. M.</given-names></name> <name><surname>Lee</surname> <given-names>K. K.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Localization of Mycoplasma pneumoniae cytadherence-associated protein HMW2 by fusion with green fluorescent protein: Implications for attachment organelle structure.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>47</volume> <fpage>49</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03282.x</pub-id> <pub-id pub-id-type="pmid">12492853</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname> <given-names>L.</given-names></name> <name><surname>Kong</surname> <given-names>H.</given-names></name> <name><surname>Ja</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Qin</surname> <given-names>L.</given-names></name> <name><surname>Sun</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>The relationship between cancer and biomechanics.</article-title> <source><italic>Front. Oncol.</italic></source> <volume>13</volume>:<fpage>1273154</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2023.1273154</pub-id> <pub-id pub-id-type="pmid">37901315</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname> <given-names>A.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Taylor</surname> <given-names>A. B.</given-names></name> <name><surname>Pakhomova</surname> <given-names>O. N.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Somarajan</surname> <given-names>S. R.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.</article-title> <source><italic>Proc. Natl. Acad. Sci. U S A.</italic></source> <volume>112</volume> <fpage>5165</fpage>&#x2013;<lpage>5170</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1420308112</pub-id> <pub-id pub-id-type="pmid">25848012</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bement</surname> <given-names>W. M.</given-names></name> <name><surname>Goryachev</surname> <given-names>A. B.</given-names></name> <name><surname>Miller</surname> <given-names>A. L.</given-names></name> <name><surname>von Dassow</surname> <given-names>G.</given-names></name></person-group> (<year>2024</year>). <article-title>Patterning of the cell cortex by Rho GTPases.</article-title> <source><italic>Nat. Rev. Mol. Cell. Biol.</italic></source> <volume>25</volume> <fpage>290</fpage>&#x2013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-023-00682-z</pub-id> <pub-id pub-id-type="pmid">38172611</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blotz</surname> <given-names>C.</given-names></name> <name><surname>Stulke</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Glycerol metabolism and its implication in virulence in Mycoplasma.</article-title> <source><italic>FEMS Microbiol. Rev.</italic></source> <volume>41</volume> <fpage>640</fpage>&#x2013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1093/femsre/fux033</pub-id> <pub-id pub-id-type="pmid">28961963</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chastney</surname> <given-names>M. R.</given-names></name> <name><surname>Kaivola</surname> <given-names>J.</given-names></name> <name><surname>Leppanen</surname> <given-names>V. M.</given-names></name> <name><surname>Ivaska</surname> <given-names>J.</given-names></name></person-group> (<year>2025</year>). <article-title>The role and regulation of integrins in cell migration and invasion.</article-title> <source><italic>Nat. Rev. Mol. Cell. Biol.</italic></source> <volume>26</volume> <fpage>147</fpage>&#x2013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-024-00777-1</pub-id> <pub-id pub-id-type="pmid">39349749</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname> <given-names>R.</given-names></name> <name><surname>Ghosh</surname> <given-names>A.</given-names></name> <name><surname>Chandolia</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Pathogenesis of Mycoplasma pneumoniae: An update.</article-title> <source><italic>Indian J. Med. Microbiol.</italic></source> <volume>34</volume> <fpage>7</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.4103/0255-0857.174112</pub-id> <pub-id pub-id-type="pmid">26776112</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname> <given-names>R.</given-names></name> <name><surname>Nisar</surname> <given-names>N.</given-names></name> <name><surname>Hora</surname> <given-names>B.</given-names></name> <name><surname>Chirasani</surname> <given-names>S. R.</given-names></name> <name><surname>Malhotra</surname> <given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Expression and immunological characterization of the carboxy-terminal region of the P1 adhesin protein of Mycoplasma pneumoniae.</article-title> <source><italic>J. Clin. Microbiol.</italic></source> <volume>43</volume> <fpage>321</fpage>&#x2013;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.43.1.321-325.2005</pub-id> <pub-id pub-id-type="pmid">15634989</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Yong</surname> <given-names>Q.</given-names></name> <name><surname>Jun</surname> <given-names>G.</given-names></name> <name><surname>Ying</surname> <given-names>P.</given-names></name> <name><surname>Suqin</surname> <given-names>L.</given-names></name> <name><surname>Jiameng</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Designing, expression and immunological characterization of a chimeric protein of Mycoplasma pneumoniae.</article-title> <source><italic>Protein. Pept. Lett.</italic></source> <volume>23</volume> <fpage>592</fpage>&#x2013;<lpage>596</lpage>. <pub-id pub-id-type="doi">10.2174/0929866523666160502155414</pub-id> <pub-id pub-id-type="pmid">27137129</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>S. Y.</given-names></name> <name><surname>Choi</surname> <given-names>Y. J.</given-names></name> <name><surname>Choi</surname> <given-names>J. H.</given-names></name> <name><surname>Choi</surname> <given-names>K. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Isolated optic neuritis associated with Mycoplasma pneumoniae infection: Report of two cases and literature review.</article-title> <source><italic>Neurol. Sci.</italic></source> <volume>38</volume> <fpage>1323</fpage>&#x2013;<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-017-2922-9</pub-id> <pub-id pub-id-type="pmid">28321515</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cloward</surname> <given-names>J. M.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Functional domain analysis of the Mycoplasma pneumoniae co-chaperone TopJ.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>77</volume> <fpage>158</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07196.x</pub-id> <pub-id pub-id-type="pmid">20487283</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cloward</surname> <given-names>J. M.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Loss of co-chaperone TopJ impacts adhesin P1 presentation and terminal organelle maturation in Mycoplasma pneumoniae.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>81</volume> <fpage>528</fpage>&#x2013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07712.x</pub-id> <pub-id pub-id-type="pmid">21631602</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dallo</surname> <given-names>S. F.</given-names></name> <name><surname>Chavoya</surname> <given-names>A.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>1990</year>). <article-title>Characterization of the gene for a 30-kilodalton adhesion-related protein of Mycoplasma pneumoniae.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>58</volume> <fpage>4163</fpage>&#x2013;<lpage>4165</lpage>. <pub-id pub-id-type="doi">10.1128/iai.58.12.4163-4165.1990</pub-id> <pub-id pub-id-type="pmid">2123834</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dallo</surname> <given-names>S. F.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Blaylock</surname> <given-names>M. W.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>2002</year>). <article-title>Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>46</volume> <fpage>1041</fpage>&#x2013;<lpage>1051</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03207.x</pub-id> <pub-id pub-id-type="pmid">12421310</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Groot</surname> <given-names>R. C. A.</given-names></name> <name><surname>Estevao</surname> <given-names>S. C.</given-names></name> <name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>Perkasa</surname> <given-names>A.</given-names></name> <name><surname>Hoogenboezem</surname> <given-names>T.</given-names></name> <name><surname>Spuesens</surname> <given-names>E. B. M.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Mycoplasma pneumoniae carriage evades induction of protective mucosal antibodies.</article-title> <source><italic>Eur. Respir. J.</italic></source> <volume>59</volume>:<fpage>2100129</fpage>. <pub-id pub-id-type="doi">10.1183/13993003.00129-2021</pub-id> <pub-id pub-id-type="pmid">34561284</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Groot</surname> <given-names>R. C. A.</given-names></name> <name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>Unger</surname> <given-names>W. W. J.</given-names></name> <name><surname>van Rossum</surname> <given-names>A. M. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Things that could be Mycoplasma pneumoniae.</article-title> <source><italic>J. Infect.</italic></source> <volume>74</volume> <fpage>S95</fpage>&#x2013;<lpage>S100</lpage>. <pub-id pub-id-type="doi">10.1016/S0163-4453(17)30198-6</pub-id> <pub-id pub-id-type="pmid">28646969</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>X.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Dai</surname> <given-names>P.</given-names></name> <name><surname>Yu</surname> <given-names>M.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Zhu</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Three polypeptides screened from phage display random peptide library may be the receptor polypeptide of Mycoplasma genitalium adhesion protein.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>120</volume> <fpage>140</fpage>&#x2013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2018.04.058</pub-id> <pub-id pub-id-type="pmid">29709687</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname> <given-names>V. P.</given-names></name> <name><surname>Herbert</surname> <given-names>A. P.</given-names></name> <name><surname>Hocking</surname> <given-names>H. G.</given-names></name> <name><surname>Barlow</surname> <given-names>P. N.</given-names></name> <name><surname>Pangburn</surname> <given-names>M. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.</article-title> <source><italic>J. Immunol.</italic></source> <volume>177</volume> <fpage>6308</fpage>&#x2013;<lpage>6316</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.9.6308</pub-id> <pub-id pub-id-type="pmid">17056561</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galgowski</surname> <given-names>C.</given-names></name> <name><surname>Pavanelo Frare</surname> <given-names>S.</given-names></name> <name><surname>Rau</surname> <given-names>M.</given-names></name> <name><surname>Debiase Alberton</surname> <given-names>M.</given-names></name> <name><surname>Althoff</surname> <given-names>S.</given-names></name> <name><surname>Guedes</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Mollicute anti-adhesive and growth inhibition properties of the methanolic extract of propolis from the brazilian native bee melipona quadrifasciata.</article-title> <source><italic>Chem. Biodivers.</italic></source> <volume>18</volume>:<fpage>e2000711</fpage>. <pub-id pub-id-type="doi">10.1002/cbdv.202000711</pub-id> <pub-id pub-id-type="pmid">33200537</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>L.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: A review.</article-title> <source><italic>Ann. Med.</italic></source> <volume>56</volume>:<fpage>2386636</fpage>. <pub-id pub-id-type="doi">10.1080/07853890.2024.2386636</pub-id> <pub-id pub-id-type="pmid">39097794</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grimmer</surname> <given-names>J.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Organization of multi-binding to host proteins: The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Mycoplasma pneumoniae.</article-title> <source><italic>Microbiol. Res.</italic></source> <volume>218</volume> <fpage>22</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2018.09.006</pub-id> <pub-id pub-id-type="pmid">30454655</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grosshennig</surname> <given-names>S.</given-names></name> <name><surname>Schmidl</surname> <given-names>S. R.</given-names></name> <name><surname>Schmeisky</surname> <given-names>G.</given-names></name> <name><surname>Busse</surname> <given-names>J.</given-names></name> <name><surname>Stulke</surname> <given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>81</volume> <fpage>896</fpage>&#x2013;<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01212-12</pub-id> <pub-id pub-id-type="pmid">23297388</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grundel</surname> <given-names>A.</given-names></name> <name><surname>Friedrich</surname> <given-names>K.</given-names></name> <name><surname>Pfeiffer</surname> <given-names>M.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Subunits of the pyruvate dehydrogenase cluster of mycoplasma pneumoniae are surface-displayed proteins that bind and activate human plasminogen.</article-title> <source><italic>PLoS One</italic></source> <volume>10</volume>:<fpage>e0126600</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0126600</pub-id> <pub-id pub-id-type="pmid">25978044</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grundel</surname> <given-names>A.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Interactions of surface-displayed glycolytic enzymes of Mycoplasma pneumoniae with components of the human extracellular matrix.</article-title> <source><italic>Int. J. Med. Microbiol.</italic></source> <volume>306</volume> <fpage>675</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2016.09.001</pub-id> <pub-id pub-id-type="pmid">27616280</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gr&#x00FC;ndel</surname> <given-names>A.</given-names></name> <name><surname>Pfeiffer</surname> <given-names>M.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Network of surface-displayed glycolytic enzymes in mycoplasma pneumoniae and their interactions with human plasminogen.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>84</volume> <fpage>666</fpage>&#x2013;<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1128/iai.01071-15</pub-id> <pub-id pub-id-type="pmid">26667841</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname> <given-names>T. W.</given-names></name> <name><surname>Willby</surname> <given-names>M. J.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>1998</year>). <article-title>HMW1 is required for cytadhesin P1 trafficking to the attachment organelle in Mycoplasma pneumoniae.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>180</volume> <fpage>1270</fpage>&#x2013;<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.1128/JB.180.5.1270-1276.1998</pub-id> <pub-id pub-id-type="pmid">9495768</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halbedel</surname> <given-names>S.</given-names></name> <name><surname>Hames</surname> <given-names>C.</given-names></name> <name><surname>Stulke</surname> <given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Regulation of carbon metabolism in the mollicutes and its relation to virulence.</article-title> <source><italic>J. Mol. Microbiol. Biotechnol.</italic></source> <volume>12</volume> <fpage>147</fpage>&#x2013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1159/000096470</pub-id> <pub-id pub-id-type="pmid">17183222</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasselbring</surname> <given-names>B. M.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Proteins P24 and P41 function in the regulation of terminal-organelle development and gliding motility in Mycoplasma pneumoniae.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>189</volume> <fpage>7442</fpage>&#x2013;<lpage>7449</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00867-07</pub-id> <pub-id pub-id-type="pmid">17693502</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasselbring</surname> <given-names>B. M.</given-names></name> <name><surname>Jordan</surname> <given-names>J. L.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Mutant analysis reveals a specific requirement for protein P30 in Mycoplasma pneumoniae gliding motility.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>187</volume> <fpage>6281</fpage>&#x2013;<lpage>6289</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.18.6281-6289.2005</pub-id> <pub-id pub-id-type="pmid">16159760</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hausner</surname> <given-names>M.</given-names></name> <name><surname>Schamberger</surname> <given-names>A.</given-names></name> <name><surname>Naumann</surname> <given-names>W.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>64</volume> <fpage>23</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2013.07.004</pub-id> <pub-id pub-id-type="pmid">23948467</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname> <given-names>S.</given-names></name> <name><surname>Rausch</surname> <given-names>C. M.</given-names></name> <name><surname>McCanta</surname> <given-names>A. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Constrictive pericarditis secondary to infection with Mycoplasma pneumoniae.</article-title> <source><italic>Curr. Opin. Pediatr.</italic></source> <volume>23</volume> <fpage>126</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1097/MOP.0b013e328341579c</pub-id> <pub-id pub-id-type="pmid">21107263</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>M.</given-names></name> <name><surname>Ye</surname> <given-names>Z.</given-names></name> <name><surname>Tan</surname> <given-names>T.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>You</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Insights into the pathogenesis of Mycoplasma pneumoniae (Review).</article-title> <source><italic>Mol. Med. Rep.</italic></source> <volume>14</volume> <fpage>4030</fpage>&#x2013;<lpage>4036</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2016.5765</pub-id> <pub-id pub-id-type="pmid">27667580</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Zeng</surname> <given-names>Y.</given-names></name> <name><surname>You</surname> <given-names>X.</given-names></name> <name><surname>Ma</surname> <given-names>X.</given-names></name> <name><surname>Wu</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Binding of CD14 to Mycoplasma genitalium-derived lipid-associated membrane proteins upregulates TNF-alpha.</article-title> <source><italic>Inflammation</italic></source> <volume>37</volume> <fpage>322</fpage>&#x2013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-013-9743-7</pub-id> <pub-id pub-id-type="pmid">24068451</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>You</surname> <given-names>X.</given-names></name> <name><surname>Zeng</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>M.</given-names></name> <name><surname>Zuo</surname> <given-names>L.</given-names></name> <name><surname>Wu</surname> <given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Mycoplasma genitalium-derived lipid-associated membrane proteins activate NF-kappaB through toll-like receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway.</article-title> <source><italic>Clin. Vaccine Immunol.</italic></source> <volume>16</volume> <fpage>1750</fpage>&#x2013;<lpage>1757</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00281-09</pub-id> <pub-id pub-id-type="pmid">19793902</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hentrich</surname> <given-names>K.</given-names></name> <name><surname>Lofling</surname> <given-names>J.</given-names></name> <name><surname>Pathak</surname> <given-names>A.</given-names></name> <name><surname>Nizet</surname> <given-names>V.</given-names></name> <name><surname>Varki</surname> <given-names>A.</given-names></name> <name><surname>Henriques-Normark</surname> <given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Streptococcus pneumoniae senses a human-like sialic acid profile via the response regulator CiaR.</article-title> <source><italic>Cell Host Microbe</italic></source> <volume>20</volume> <fpage>307</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2016.07.019</pub-id> <pub-id pub-id-type="pmid">27593514</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoek</surname> <given-names>K. L.</given-names></name> <name><surname>Duffy</surname> <given-names>L. B.</given-names></name> <name><surname>Cassell</surname> <given-names>G. H.</given-names></name> <name><surname>Dai</surname> <given-names>Y.</given-names></name> <name><surname>Atkinson</surname> <given-names>T. P.</given-names></name></person-group> (<year>2005</year>). <article-title>A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>39</volume> <fpage>149</fpage>&#x2013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2005.07.004</pub-id> <pub-id pub-id-type="pmid">16169702</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>W.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Zou</surname> <given-names>J.</given-names></name> <name><surname>Bi</surname> <given-names>Z.</given-names></name> <name><surname>He</surname> <given-names>C.</given-names></name> <name><surname>Lei</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells.</article-title> <source><italic>Cell. Mol. Immunol.</italic></source> <volume>19</volume> <fpage>577</fpage>&#x2013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1038/s41423-022-00845-6</pub-id> <pub-id pub-id-type="pmid">35273357</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>J.</given-names></name> <name><surname>Ye</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Xiong</surname> <given-names>L.</given-names></name> <name><surname>Xie</surname> <given-names>W.</given-names></name> <name><surname>Liu</surname> <given-names>P.</given-names></name></person-group> (<year>2022</year>). <article-title>Insight into the pathogenic mechanism of Mycoplasma pneumoniae.</article-title> <source><italic>Curr. Microbiol.</italic></source> <volume>80</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1007/s00284-022-03103-0</pub-id> <pub-id pub-id-type="pmid">36459213</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>L.</given-names></name> <name><surname>Huang</surname> <given-names>X.</given-names></name> <name><surname>Jiang</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name> <name><surname>Yan</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>Independent predictors for longer radiographic resolution in patients with refractory Mycoplasma pneumoniae pneumonia: A prospective cohort study.</article-title> <source><italic>BMJ Open</italic></source> <volume>8</volume>:<fpage>e023719</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2018-023719</pub-id> <pub-id pub-id-type="pmid">30567824</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Into</surname> <given-names>T.</given-names></name> <name><surname>Dohkan</surname> <given-names>J.</given-names></name> <name><surname>Inomata</surname> <given-names>M.</given-names></name> <name><surname>Nakashima</surname> <given-names>M.</given-names></name> <name><surname>Shibata</surname> <given-names>K.</given-names></name> <name><surname>Matsushita</surname> <given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>75</volume> <fpage>2253</fpage>&#x2013;<lpage>2259</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00141-07</pub-id> <pub-id pub-id-type="pmid">17325056</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>F. C.</given-names></name> <name><surname>Wang</surname> <given-names>R. F.</given-names></name> <name><surname>Chen</surname> <given-names>P.</given-names></name> <name><surname>Dong</surname> <given-names>L. Y.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Song</surname> <given-names>Q.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Genotype and mutation patterns of macrolide resistance genes of Mycoplasma pneumoniae from children with pneumonia in Qingdao. China, in 2019.</article-title> <source><italic>J. Glob. Antimicrob. Resist.</italic></source> <volume>27</volume> <fpage>273</fpage>&#x2013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgar.2021.10.003</pub-id> <pub-id pub-id-type="pmid">34687926</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>D.</given-names></name> <name><surname>Du</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2025</year>). <article-title>Nano-polymeric platinum activates PAR2 gene editing to suppress tumor metastasis.</article-title> <source><italic>Biomaterials</italic></source> <volume>317</volume>:<fpage>123090</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2025.123090</pub-id> <pub-id pub-id-type="pmid">39799696</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Zhu</surname> <given-names>C.</given-names></name> <name><surname>Zhou</surname> <given-names>R.</given-names></name> <name><surname>Leung</surname> <given-names>P. H. M.</given-names></name></person-group> (<year>2021</year>). <article-title>Mycoplasma pneumoniae infections: Pathogenesis and vaccine development.</article-title> <source><italic>Pathogens</italic></source> <volume>10</volume>:<fpage>119</fpage>. <pub-id pub-id-type="doi">10.3390/pathogens10020119</pub-id> <pub-id pub-id-type="pmid">33503845</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>C.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments.</article-title> <source><italic>PLoS One</italic></source> <volume>6</volume>:<fpage>e22877</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022877</pub-id> <pub-id pub-id-type="pmid">21829543</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>M. C.</given-names></name> <name><surname>Zha</surname> <given-names>J.</given-names></name> <name><surname>Humphries</surname> <given-names>M. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Connections between the cell cycle, cell adhesion and the cytoskeleton.</article-title> <source><italic>Philos. Trans. R Soc. Lond. B Biol. Sci.</italic></source> <volume>374</volume>:<fpage>20180227</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2018.0227</pub-id> <pub-id pub-id-type="pmid">31431178</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname> <given-names>J. L.</given-names></name> <name><surname>Chang</surname> <given-names>H. Y.</given-names></name> <name><surname>Balish</surname> <given-names>M. F.</given-names></name> <name><surname>Holt</surname> <given-names>L. S.</given-names></name> <name><surname>Bose</surname> <given-names>S. R.</given-names></name> <name><surname>Hasselbring</surname> <given-names>B. M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>75</volume> <fpage>518</fpage>&#x2013;<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01344-06</pub-id> <pub-id pub-id-type="pmid">17043103</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamranvar</surname> <given-names>S. A.</given-names></name> <name><surname>Rani</surname> <given-names>B.</given-names></name> <name><surname>Johansson</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Cell cycle regulation by integrin-mediated adhesion.</article-title> <source><italic>Cells</italic></source> <volume>11</volume>:<fpage>2521</fpage>. <pub-id pub-id-type="doi">10.3390/cells11162521</pub-id> <pub-id pub-id-type="pmid">36010598</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanchanawong</surname> <given-names>P.</given-names></name> <name><surname>Calderwood</surname> <given-names>D. A.</given-names></name></person-group> (<year>2023</year>). <article-title>Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions.</article-title> <source><italic>Nat. Rev. Mol. Cell. Biol.</italic></source> <volume>24</volume> <fpage>142</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-022-00531-5</pub-id> <pub-id pub-id-type="pmid">36168065</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname> <given-names>K.</given-names></name> <name><surname>Vazquez-Laslop</surname> <given-names>N.</given-names></name> <name><surname>Mankin</surname> <given-names>A. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.</article-title> <source><italic>Cell</italic></source> <volume>151</volume> <fpage>508</fpage>&#x2013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.09.018</pub-id> <pub-id pub-id-type="pmid">23101624</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>2006</year>). <article-title>ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.</article-title> <source><italic>Proc. Natl. Acad. Sci. U S A.</italic></source> <volume>103</volume> <fpage>6724</fpage>&#x2013;<lpage>6729</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510644103</pub-id> <pub-id pub-id-type="pmid">16617115</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Krishnan</surname> <given-names>M.</given-names></name> <name><surname>Ramasamy</surname> <given-names>K.</given-names></name> <name><surname>Becker</surname> <given-names>A.</given-names></name> <name><surname>Pakhomova</surname> <given-names>O. N.</given-names></name> <name><surname>Hart</surname> <given-names>P. J.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>93</volume> <fpage>568</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.12680</pub-id> <pub-id pub-id-type="pmid">24948331</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Musatovova</surname> <given-names>O.</given-names></name> <name><surname>Balasubramanian</surname> <given-names>S.</given-names></name> <name><surname>Cagle</surname> <given-names>M.</given-names></name> <name><surname>Jordan</surname> <given-names>J. L.</given-names></name> <name><surname>Krunkosky</surname> <given-names>T. M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection-dependent regulation.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>76</volume> <fpage>1127</fpage>&#x2013;<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07092.x</pub-id> <pub-id pub-id-type="pmid">20199607</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karamanos</surname> <given-names>N. K.</given-names></name> <name><surname>Theocharis</surname> <given-names>A. D.</given-names></name> <name><surname>Piperigkou</surname> <given-names>Z.</given-names></name> <name><surname>Manou</surname> <given-names>D.</given-names></name> <name><surname>Passi</surname> <given-names>A.</given-names></name> <name><surname>Skandalis</surname> <given-names>S. S.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>A guide to the composition and functions of the extracellular matrix.</article-title> <source><italic>FEBS J.</italic></source> <volume>288</volume> <fpage>6850</fpage>&#x2013;<lpage>6912</lpage>. <pub-id pub-id-type="doi">10.1111/febs.15776</pub-id> <pub-id pub-id-type="pmid">33605520</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kasai</surname> <given-names>T.</given-names></name> <name><surname>Nakane</surname> <given-names>D.</given-names></name> <name><surname>Ishida</surname> <given-names>H.</given-names></name> <name><surname>Ando</surname> <given-names>H.</given-names></name> <name><surname>Kiso</surname> <given-names>M.</given-names></name> <name><surname>Miyata</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of binding in Mycoplasma mobile and Mycoplasma pneumoniae gliding analyzed through inhibition by synthesized sialylated compounds.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>195</volume> <fpage>429</fpage>&#x2013;<lpage>435</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01141-12</pub-id> <pub-id pub-id-type="pmid">23123913</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kashyap</surname> <given-names>S.</given-names></name> <name><surname>Sarkar</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Mycoplasma pneumonia: Clinical features and management.</article-title> <source><italic>Lung India</italic></source> <volume>27</volume> <fpage>75</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.4103/0970-2113.63611</pub-id> <pub-id pub-id-type="pmid">20616940</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawakita</surname> <given-names>Y.</given-names></name> <name><surname>Kinoshita</surname> <given-names>M.</given-names></name> <name><surname>Furukawa</surname> <given-names>Y.</given-names></name> <name><surname>Tulum</surname> <given-names>I.</given-names></name> <name><surname>Tahara</surname> <given-names>Y. O.</given-names></name> <name><surname>Katayama</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Structural study of MPN387, an essential protein for gliding motility of a human-pathogenic bacterium, Mycoplasma pneumoniae.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>198</volume> <fpage>2352</fpage>&#x2013;<lpage>2359</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00160-16</pub-id> <pub-id pub-id-type="pmid">27325681</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname> <given-names>A.</given-names></name> <name><surname>Matsuo</surname> <given-names>L.</given-names></name> <name><surname>Kato</surname> <given-names>T.</given-names></name> <name><surname>Yamamoto</surname> <given-names>H.</given-names></name> <name><surname>Namba</surname> <given-names>K.</given-names></name> <name><surname>Miyata</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Periodicity in attachment organelle revealed by electron cryotomography suggests conformational changes in gliding mechanism of mycoplasma pneumoniae.</article-title> <source><italic>mBio</italic></source> <volume>7</volume>:<fpage>e00243-16</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.00243-16</pub-id> <pub-id pub-id-type="pmid">27073090</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenri</surname> <given-names>T.</given-names></name> <name><surname>Kawakita</surname> <given-names>Y.</given-names></name> <name><surname>Kudo</surname> <given-names>H.</given-names></name> <name><surname>Matsumoto</surname> <given-names>U.</given-names></name> <name><surname>Mori</surname> <given-names>S.</given-names></name> <name><surname>Furukawa</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Production and characterization of recombinant P1 adhesin essential for adhesion, gliding, and antigenic variation in the human pathogenic bacterium, Mycoplasma pneumoniae.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>508</volume> <fpage>1050</fpage>&#x2013;<lpage>1055</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.11.132</pub-id> <pub-id pub-id-type="pmid">30551878</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kenri</surname> <given-names>T.</given-names></name> <name><surname>Okazaki</surname> <given-names>N.</given-names></name> <name><surname>Yamazaki</surname> <given-names>T.</given-names></name> <name><surname>Narita</surname> <given-names>M.</given-names></name> <name><surname>Izumikawa</surname> <given-names>K.</given-names></name> <name><surname>Matsuoka</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: Type shift phenomenon of M. pneumoniae clinical strains.</article-title> <source><italic>J. Med. Microbiol.</italic></source> <volume>57</volume> <fpage>469</fpage>&#x2013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.47634-0</pub-id> <pub-id pub-id-type="pmid">18349367</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koenen</surname> <given-names>M. H.</given-names></name> <name><surname>de Groot</surname> <given-names>R. C. A.</given-names></name> <name><surname>de Steenhuijsen Piters</surname> <given-names>W. A. A.</given-names></name> <name><surname>Chu</surname> <given-names>M.</given-names></name> <name><surname>Arp</surname> <given-names>K.</given-names></name> <name><surname>Hasrat</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Mycoplasma pneumoniae carriage in children with recurrent respiratory tract infections is associated with a less diverse and altered microbiota.</article-title> <source><italic>EBioMedicine</italic></source> <volume>98</volume>:<fpage>104868</fpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2023.104868</pub-id> <pub-id pub-id-type="pmid">37950996</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname> <given-names>D. C.</given-names></name> <name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Shi</surname> <given-names>J.</given-names></name> <name><surname>Jensen</surname> <given-names>A. J.</given-names></name> <name><surname>Sheppard</surname> <given-names>E. S.</given-names></name> <name><surname>Jensen</surname> <given-names>G. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Electron cryotomography of Mycoplasma pneumoniae mutants correlates terminal organelle architectural features and function.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>108</volume> <fpage>306</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.13937</pub-id> <pub-id pub-id-type="pmid">29470845</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname> <given-names>M.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis.</article-title> <source><italic>PLoS One</italic></source> <volume>8</volume>:<fpage>e62706</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062706</pub-id> <pub-id pub-id-type="pmid">23667510</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname> <given-names>K. M.</given-names></name> <name><surname>Barbieri</surname> <given-names>J. T.</given-names></name></person-group> (<year>1995</year>). <article-title>The family of bacterial ADP-ribosylating exotoxins.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>8</volume> <fpage>34</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.8.1.34</pub-id> <pub-id pub-id-type="pmid">7704894</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections.</article-title> <source><italic>Indian J. Med. Res.</italic></source> <volume>147</volume> <fpage>23</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.4103/ijmr.IJMR_1582_16</pub-id> <pub-id pub-id-type="pmid">29749357</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J. K.</given-names></name> <name><surname>Seong</surname> <given-names>M. W.</given-names></name> <name><surname>Shin</surname> <given-names>D.</given-names></name> <name><surname>Kim</surname> <given-names>J. I.</given-names></name> <name><surname>Han</surname> <given-names>M. S.</given-names></name> <name><surname>Yeon</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Comparative genomics of Mycoplasma pneumoniae isolated from children with pneumonia: South Korea, 2010-2016.</article-title> <source><italic>BMC Genomics</italic></source> <volume>20</volume>:<fpage>910</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-019-6306-9</pub-id> <pub-id pub-id-type="pmid">31783732</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Zhou</surname> <given-names>Z.</given-names></name></person-group> (<year>2024</year>). <article-title>Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China.</article-title> <source><italic>Lancet Microbe</italic></source> <volume>5</volume> <issue>e515</issue>. <pub-id pub-id-type="doi">10.1016/S2666-5247(23)00405-6</pub-id> <pub-id pub-id-type="pmid">38244553</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Luo</surname> <given-names>D.</given-names></name> <name><surname>Liao</surname> <given-names>Y.</given-names></name> <name><surname>Peng</surname> <given-names>K.</given-names></name> <name><surname>Zeng</surname> <given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Mycoplasma genitalium protein of adhesion induces inflammatory cytokines via cyclophilin A-CD147 activating the ERK-NF-kappaB pathway in human urothelial cells.</article-title> <source><italic>Front. Immunol.</italic></source> <volume>11</volume>:<fpage>2052</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2020.02052</pub-id> <pub-id pub-id-type="pmid">33013867</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Ma</surname> <given-names>J.</given-names></name> <name><surname>Guo</surname> <given-names>P.</given-names></name> <name><surname>Song</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Yu</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children.</article-title> <source><italic>BMC Infect. Dis.</italic></source> <volume>22</volume>:<fpage>724</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-022-07715-6</pub-id> <pub-id pub-id-type="pmid">36068499</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>H.</given-names></name> <name><surname>Jiang</surname> <given-names>W.</given-names></name> <name><surname>Han</surname> <given-names>Q.</given-names></name> <name><surname>Liu</surname> <given-names>F.</given-names></name> <name><surname>Zhao</surname> <given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Ciliary ultrastructural abnormalities in Mycoplasma pneumoniae pneumonia in 22 pediatric patients.</article-title> <source><italic>Eur. J. Pediatr.</italic></source> <volume>171</volume> <fpage>559</fpage>&#x2013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1007/s00431-011-1609-0</pub-id> <pub-id pub-id-type="pmid">22037759</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y.</given-names></name> <name><surname>Deng</surname> <given-names>X.</given-names></name> <name><surname>Peng</surname> <given-names>K.</given-names></name> <name><surname>Dai</surname> <given-names>P.</given-names></name> <name><surname>Luo</surname> <given-names>D.</given-names></name> <name><surname>Liu</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Identification of histone H2B as a potential receptor for Mycoplasma genitalium protein of adhesion.</article-title> <source><italic>Pathog. Dis.</italic></source> <volume>79</volume>:<fpage>ftab053</fpage>. <pub-id pub-id-type="doi">10.1093/femspd/ftab053</pub-id> <pub-id pub-id-type="pmid">34755841</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liesman</surname> <given-names>R. M.</given-names></name> <name><surname>Buchholz</surname> <given-names>U. J.</given-names></name> <name><surname>Luongo</surname> <given-names>C. L.</given-names></name> <name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Proia</surname> <given-names>A. D.</given-names></name> <name><surname>DeVincenzo</surname> <given-names>J. P.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.</article-title> <source><italic>J. Clin. Invest.</italic></source> <volume>124</volume> <fpage>2219</fpage>&#x2013;<lpage>2233</lpage>. <pub-id pub-id-type="doi">10.1172/JCI72948</pub-id> <pub-id pub-id-type="pmid">24713657</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>J.</given-names></name> <name><surname>Zhou</surname> <given-names>D.</given-names></name> <name><surname>Steitz</surname> <given-names>T. A.</given-names></name> <name><surname>Polikanov</surname> <given-names>Y. S.</given-names></name> <name><surname>Gagnon</surname> <given-names>M. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design.</article-title> <source><italic>Annu. Rev. Biochem.</italic></source> <volume>87</volume> <fpage>451</fpage>&#x2013;<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-062917-011942</pub-id> <pub-id pub-id-type="pmid">29570352</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>He</surname> <given-names>R.</given-names></name> <name><surname>Wu</surname> <given-names>R.</given-names></name> <name><surname>Wang</surname> <given-names>B.</given-names></name> <name><surname>Xu</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children&#x2019;s hospital.</article-title> <source><italic>BMC Infect. Dis.</italic></source> <volume>20</volume>:<fpage>51</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-020-4774-9</pub-id> <pub-id pub-id-type="pmid">31948402</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname> <given-names>J. A.</given-names></name> <name><surname>Kaur</surname> <given-names>G.</given-names></name> <name><surname>Agrewala</surname> <given-names>J. N.</given-names></name></person-group> (<year>2023</year>). <article-title>Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity.</article-title> <source><italic>Int. J. Biol. Macromol.</italic></source> <volume>253</volume>:<fpage>127252</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.127252</pub-id> <pub-id pub-id-type="pmid">37802429</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mara</surname> <given-names>A. B.</given-names></name> <name><surname>Gavitt</surname> <given-names>T. D.</given-names></name> <name><surname>Tulman</surname> <given-names>E. R.</given-names></name> <name><surname>Geary</surname> <given-names>S. J.</given-names></name> <name><surname>Szczepanek</surname> <given-names>S. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease.</article-title> <source><italic>NPJ Vaccines</italic></source> <volume>5</volume>:<fpage>31</fpage>. <pub-id pub-id-type="doi">10.1038/s41541-020-0181-x</pub-id> <pub-id pub-id-type="pmid">32284882</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mara</surname> <given-names>A. B.</given-names></name> <name><surname>Gavitt</surname> <given-names>T. D.</given-names></name> <name><surname>Tulman</surname> <given-names>E. R.</given-names></name> <name><surname>Miller</surname> <given-names>J. M.</given-names></name> <name><surname>He</surname> <given-names>W.</given-names></name> <name><surname>Reinhardt</surname> <given-names>E. M.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates vaccine-enhanced disease.</article-title> <source><italic>NPJ Vaccines</italic></source> <volume>7</volume>:<fpage>86</fpage>. <pub-id pub-id-type="doi">10.1038/s41541-022-00513-w</pub-id> <pub-id pub-id-type="pmid">35906257</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marc</surname> <given-names>G.</given-names></name> <name><surname>Araniciu</surname> <given-names>C.</given-names></name> <name><surname>Oniga</surname> <given-names>S. D.</given-names></name> <name><surname>Vlase</surname> <given-names>L.</given-names></name> <name><surname>Pirnau</surname> <given-names>A.</given-names></name> <name><surname>Duma</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>New N-(oxazolylmethyl)-thiazolidinedione active against Candida albicans biofilm: Potential als proteins inhibitors.</article-title> <source><italic>Molecules</italic></source> <volume>23</volume>:<fpage>2522</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23102522</pub-id> <pub-id pub-id-type="pmid">30279343</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marseglia</surname> <given-names>A.</given-names></name> <name><surname>Forgione</surname> <given-names>M. C.</given-names></name> <name><surname>Marcos-Silva</surname> <given-names>M.</given-names></name> <name><surname>Di Carluccio</surname> <given-names>C.</given-names></name> <name><surname>Manabe</surname> <given-names>Y.</given-names></name> <name><surname>Vizarraga</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Molecular basis of bacterial lectin recognition of eukaryotic glycans: The case of Mycoplasma pneumoniae and Mycoplasma genitalium cytoadhesins.</article-title> <source><italic>Int. J. Biol. Macromol.</italic></source> <volume>279</volume>:<fpage>135277</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.135277</pub-id> <pub-id pub-id-type="pmid">39226978</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matrullo</surname> <given-names>G.</given-names></name> <name><surname>Filomeni</surname> <given-names>G.</given-names></name> <name><surname>Rizza</surname> <given-names>S.</given-names></name></person-group> (<year>2025</year>). <article-title>Redox regulation of focal adhesions.</article-title> <source><italic>Redox Biol.</italic></source> <volume>80</volume>:<fpage>103514</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2025.103514</pub-id> <pub-id pub-id-type="pmid">39879736</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGowin</surname> <given-names>C. L.</given-names></name> <name><surname>Totten</surname> <given-names>P. A.</given-names></name></person-group> (<year>2017</year>). <article-title>The unique microbiology and molecular pathogenesis of Mycoplasma genitalium.</article-title> <source><italic>J. Infect. Dis.</italic></source> <volume>216</volume> <fpage>S382</fpage>&#x2013;<lpage>S388</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jix172</pub-id> <pub-id pub-id-type="pmid">28838077</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>Y. L.</given-names></name> <name><surname>Wang</surname> <given-names>W. M.</given-names></name> <name><surname>Lv</surname> <given-names>D. D.</given-names></name> <name><surname>An</surname> <given-names>Q. X.</given-names></name> <name><surname>Lu</surname> <given-names>W. H.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The effect of Platycodin D on the expression of cytoadherence proteins P1 and P30 in Mycoplasma pneumoniae models.</article-title> <source><italic>Environ. Toxicol. Pharmacol.</italic></source> <volume>49</volume> <fpage>188</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2017.01.001</pub-id> <pub-id pub-id-type="pmid">28073091</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meseguer</surname> <given-names>M. A.</given-names></name> <name><surname>Alvarez</surname> <given-names>A.</given-names></name> <name><surname>Rejas</surname> <given-names>M. T.</given-names></name> <name><surname>Sanchez</surname> <given-names>C.</given-names></name> <name><surname>Perez-Diaz</surname> <given-names>J. C.</given-names></name> <name><surname>Baquero</surname> <given-names>F.</given-names></name></person-group> (<year>2003</year>). <article-title>Mycoplasma pneumoniae: A reduced-genome intracellular bacterial pathogen.</article-title> <source><italic>Infect. Genet. Evol.</italic></source> <volume>3</volume> <fpage>47</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/s1567-1348(02)00151-x</pub-id> <pub-id pub-id-type="pmid">12797972</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>de Groot</surname> <given-names>R. C. A.</given-names></name> <name><surname>Estevao</surname> <given-names>S. C.</given-names></name> <name><surname>Hoogenboezem</surname> <given-names>T.</given-names></name> <name><surname>de Bruijn</surname> <given-names>A.</given-names></name> <name><surname>Sluijter</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The role of B cells in carriage and clearance of Mycoplasma pneumoniae from the respiratory tract of mice.</article-title> <source><italic>J. Infect. Dis.</italic></source> <volume>217</volume> <fpage>298</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jix559</pub-id> <pub-id pub-id-type="pmid">29099932</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>Jacobs</surname> <given-names>B. C.</given-names></name> <name><surname>Spuesens</surname> <given-names>E. B.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Nadal</surname> <given-names>D.</given-names></name> <name><surname>Vink</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2014a</year>). <article-title>Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>10</volume>:<fpage>e1003983</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003983</pub-id> <pub-id pub-id-type="pmid">24945969</pub-id></citation></ref>
<ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>Panisova</surname> <given-names>E.</given-names></name> <name><surname>Seiler</surname> <given-names>M.</given-names></name> <name><surname>Theiler</surname> <given-names>M.</given-names></name> <name><surname>Berger</surname> <given-names>C.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>Mycoplasma pneumoniae genotypes and clinical outcome in children.</article-title> <source><italic>J. Clin. Microbiol.</italic></source> <volume>59</volume>:<fpage>e0074821</fpage>. <pub-id pub-id-type="doi">10.1128/JCM.00748-21</pub-id> <pub-id pub-id-type="pmid">33853838</pub-id></citation></ref>
<ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>Unger</surname> <given-names>W. W.</given-names></name> <name><surname>Nadal</surname> <given-names>D.</given-names></name> <name><surname>Berger</surname> <given-names>C.</given-names></name> <name><surname>Vink</surname> <given-names>C.</given-names></name> <name><surname>van Rossum</surname> <given-names>A. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Infection with and carriage of Mycoplasma pneumoniae in children.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<fpage>329</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00329</pub-id> <pub-id pub-id-type="pmid">27047456</pub-id></citation></ref>
<ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>van Rossum</surname> <given-names>A. M.</given-names></name> <name><surname>Vink</surname> <given-names>C.</given-names></name></person-group> (<year>2014b</year>). <article-title>Mycoplasma pneumoniae in children: Carriage, pathogenesis, and antibiotic resistance.</article-title> <source><italic>Curr. Opin. Infect. Dis.</italic></source> <volume>27</volume> <fpage>220</fpage>&#x2013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0000000000000063</pub-id> <pub-id pub-id-type="pmid">24751894</pub-id></citation></ref>
<ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Centipede and inchworm models to explain Mycoplasma gliding.</article-title> <source><italic>Trends Microbiol.</italic></source> <volume>16</volume> <fpage>6</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2007.11.002</pub-id> <pub-id pub-id-type="pmid">18083032</pub-id></citation></ref>
<ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname> <given-names>M.</given-names></name> <name><surname>Hamaguchi</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Integrated information and prospects for gliding mechanism of the pathogenic bacterium Mycoplasma pneumoniae.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<fpage>960</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00960</pub-id> <pub-id pub-id-type="pmid">27446003</pub-id></citation></ref>
<ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakane</surname> <given-names>D.</given-names></name> <name><surname>Kenri</surname> <given-names>T.</given-names></name> <name><surname>Matsuo</surname> <given-names>L.</given-names></name> <name><surname>Miyata</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Systematic structural analyses of attachment organelle in Mycoplasma pneumoniae.</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>11</volume>:<fpage>e1005299</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005299</pub-id> <pub-id pub-id-type="pmid">26633540</pub-id></citation></ref>
<ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.</article-title> <source><italic>J. Infect. Chemother.</italic></source> <volume>16</volume> <fpage>162</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1007/s10156-010-0044-x</pub-id> <pub-id pub-id-type="pmid">20186455</pub-id></citation></ref>
<ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narita</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00023</pub-id> <pub-id pub-id-type="pmid">26858701</pub-id></citation></ref>
<ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neimark</surname> <given-names>H.</given-names></name> <name><surname>Gesner</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Is Mycoplasma pneumoniae adherence to erythrocytes a factor in extrapulmonary dissemination?</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>6</volume>:<fpage>e1001219</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1001219</pub-id> <pub-id pub-id-type="pmid">21203479</pub-id></citation></ref>
<ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Yu</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>He</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Influenza virus uses mGluR2 as an endocytic receptor to enter cells.</article-title> <source><italic>Nat. Microbiol.</italic></source> <volume>9</volume> <fpage>1764</fpage>&#x2013;<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-024-01713-x</pub-id> <pub-id pub-id-type="pmid">38849624</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Reilly</surname> <given-names>F. J.</given-names></name> <name><surname>Xue</surname> <given-names>L.</given-names></name> <name><surname>Graziadei</surname> <given-names>A.</given-names></name> <name><surname>Sinn</surname> <given-names>L.</given-names></name> <name><surname>Lenz</surname> <given-names>S.</given-names></name> <name><surname>Tegunov</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>In-cell architecture of an actively transcribing-translating expressome.</article-title> <source><italic>Science</italic></source> <volume>369</volume> <fpage>554</fpage>&#x2013;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb3758</pub-id> <pub-id pub-id-type="pmid">32732422</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Page</surname> <given-names>C. A.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Protein kinase/phosphatase function correlates with gliding motility in Mycoplasma pneumoniae.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>195</volume> <fpage>1750</fpage>&#x2013;<lpage>1757</lpage>. <pub-id pub-id-type="doi">10.1128/JB.02277-12</pub-id> <pub-id pub-id-type="pmid">23396910</pub-id></citation></ref>
<ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>X.</given-names></name> <name><surname>He</surname> <given-names>X.</given-names></name> <name><surname>Qiu</surname> <given-names>Z.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Xie</surname> <given-names>R.</given-names></name> <name><surname>Liu</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Targeting integrin pathways: Mechanisms and advances in therapy.</article-title> <source><italic>Signal Transduct. Target Ther.</italic></source> <volume>8</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-01259-6</pub-id> <pub-id pub-id-type="pmid">36588107</pub-id></citation></ref>
<ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>W. H.</given-names></name></person-group> (<year>2013</year>). <article-title>The effects of exogenous H<sub>2</sub>O<sub>2</sub> on cell death, reactive oxygen species and glutathione levels in calf pulmonary artery and human umbilical vein endothelial cells.</article-title> <source><italic>Int. J. Mol. Med.</italic></source> <volume>31</volume> <fpage>471</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2012.1215</pub-id> <pub-id pub-id-type="pmid">23254439</pub-id></citation></ref>
<ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pereyre</surname> <given-names>S.</given-names></name> <name><surname>Goret</surname> <given-names>J.</given-names></name> <name><surname>Bebear</surname> <given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<fpage>974</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00974</pub-id> <pub-id pub-id-type="pmid">27446015</pub-id></citation></ref>
<ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pich</surname> <given-names>O. Q.</given-names></name> <name><surname>Burgos</surname> <given-names>R.</given-names></name> <name><surname>Ferrer-Navarro</surname> <given-names>M.</given-names></name> <name><surname>Querol</surname> <given-names>E.</given-names></name> <name><surname>Pinol</surname> <given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Mycoplasma genitalium mg200 and mg386 genes are involved in gliding motility but not in cytadherence.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>60</volume> <fpage>1509</fpage>&#x2013;<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05187.x</pub-id> <pub-id pub-id-type="pmid">16796684</pub-id></citation></ref>
<ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poddighe</surname> <given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: Recent insights into the pathogenesis.</article-title> <source><italic>Curr. Opin. Rheumatol.</italic></source> <volume>30</volume> <fpage>380</fpage>&#x2013;<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1097/BOR.0000000000000494</pub-id> <pub-id pub-id-type="pmid">29432224</pub-id></citation></ref>
<ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname> <given-names>O. A.</given-names></name> <name><surname>Krunkosky</surname> <given-names>T. M.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2014</year>). <article-title>In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>82</volume> <fpage>579</fpage>&#x2013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01036-13</pub-id> <pub-id pub-id-type="pmid">24478073</pub-id></citation></ref>
<ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname> <given-names>O. A.</given-names></name> <name><surname>Krunkosky</surname> <given-names>T. M.</given-names></name> <name><surname>Sheppard</surname> <given-names>E. S.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Modelling persistent Mycoplasma pneumoniae infection of human airway epithelium.</article-title> <source><italic>Cell Microbiol.</italic></source> <volume>20</volume>:<fpage>12810</fpage>. <pub-id pub-id-type="doi">10.1111/cmi.12810</pub-id> <pub-id pub-id-type="pmid">29155483</pub-id></citation></ref>
<ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pronker</surname> <given-names>M. F.</given-names></name> <name><surname>Creutznacher</surname> <given-names>R.</given-names></name> <name><surname>Drulyte</surname> <given-names>I.</given-names></name> <name><surname>Hulswit</surname> <given-names>R. J. G.</given-names></name> <name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>van Kuppeveld</surname> <given-names>F. J. M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Sialoglycan binding triggers spike opening in a human coronavirus.</article-title> <source><italic>Nature</italic></source> <volume>624</volume> <fpage>201</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-023-06599-z</pub-id> <pub-id pub-id-type="pmid">37794193</pub-id></citation></ref>
<ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>S. P.</given-names></name> <name><surname>Rasmussen</surname> <given-names>W. G.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name></person-group> (<year>1996</year>). <article-title>Correlations between Mycoplasma pneumoniae sensitivity to cyclosporin A and cyclophilin-mediated regulation of mycoplasma cytadherence.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>20</volume> <fpage>155</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1006/mpat.1996.0014</pub-id> <pub-id pub-id-type="pmid">8965676</pub-id></citation></ref>
<ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidl</surname> <given-names>S. R.</given-names></name> <name><surname>Gronau</surname> <given-names>K.</given-names></name> <name><surname>Hames</surname> <given-names>C.</given-names></name> <name><surname>Busse</surname> <given-names>J.</given-names></name> <name><surname>Becher</surname> <given-names>D.</given-names></name> <name><surname>Hecker</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The stability of cytadherence proteins in Mycoplasma pneumoniae requires activity of the protein kinase PrkC.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>78</volume> <fpage>184</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00958-09</pub-id> <pub-id pub-id-type="pmid">19858294</pub-id></citation></ref>
<ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidl</surname> <given-names>S. R.</given-names></name> <name><surname>Otto</surname> <given-names>A.</given-names></name> <name><surname>Lluch-Senar</surname> <given-names>M.</given-names></name> <name><surname>Pinol</surname> <given-names>J.</given-names></name> <name><surname>Busse</surname> <given-names>J.</given-names></name> <name><surname>Becher</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>A trigger enzyme in Mycoplasma pneumoniae: impact of the glycerophosphodiesterase GlpQ on virulence and gene expression.</article-title> <source><italic>PLoS Pathog.</italic></source> <volume>7</volume>:<fpage>e1002263</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002263</pub-id> <pub-id pub-id-type="pmid">21966272</pub-id></citation></ref>
<ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schomburg</surname> <given-names>J.</given-names></name> <name><surname>Vogel</surname> <given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>A 12-year-old boy with severe mucositis: Extrapulmonary manifestation of Mycoplasma pneumoniae infection.</article-title> <source><italic>Klin. Padiatr.</italic></source> <volume>224</volume> <fpage>94</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1055/s-0031-1299740</pub-id> <pub-id pub-id-type="pmid">22318411</pub-id></citation></ref>
<ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schurwanz</surname> <given-names>N.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>77</volume> <fpage>5007</fpage>&#x2013;<lpage>5015</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00268-09</pub-id> <pub-id pub-id-type="pmid">19667041</pub-id></citation></ref>
<ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seto</surname> <given-names>S.</given-names></name> <name><surname>Kenri</surname> <given-names>T.</given-names></name> <name><surname>Tomiyama</surname> <given-names>T.</given-names></name> <name><surname>Miyata</surname> <given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Involvement of P1 adhesin in gliding motility of Mycoplasma pneumoniae as revealed by the inhibitory effects of antibody under optimized gliding conditions.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>187</volume> <fpage>1875</fpage>&#x2013;<lpage>1877</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.5.1875-1877.2005</pub-id> <pub-id pub-id-type="pmid">15716461</pub-id></citation></ref>
<ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname> <given-names>T.</given-names></name> <name><surname>Kida</surname> <given-names>Y.</given-names></name> <name><surname>Kuwano</surname> <given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2.</article-title> <source><italic>Immunology</italic></source> <volume>121</volume> <fpage>473</fpage>&#x2013;<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2007.02594.x</pub-id> <pub-id pub-id-type="pmid">17433078</pub-id></citation></ref>
<ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname> <given-names>T.</given-names></name> <name><surname>Kida</surname> <given-names>Y.</given-names></name> <name><surname>Kuwano</surname> <given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>76</volume> <fpage>270</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00955-07</pub-id> <pub-id pub-id-type="pmid">17954722</pub-id></citation></ref>
<ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname> <given-names>T.</given-names></name> <name><surname>Kida</surname> <given-names>Y.</given-names></name> <name><surname>Kuwano</surname> <given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Cytoadherence-dependent induction of inflammatory responses by Mycoplasma pneumoniae.</article-title> <source><italic>Immunology</italic></source> <volume>133</volume> <fpage>51</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2011.03408.x</pub-id> <pub-id pub-id-type="pmid">21320122</pub-id></citation></ref>
<ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname> <given-names>T.</given-names></name> <name><surname>Kimura</surname> <given-names>Y.</given-names></name> <name><surname>Kida</surname> <given-names>Y.</given-names></name> <name><surname>Kuwano</surname> <given-names>K.</given-names></name> <name><surname>Tachibana</surname> <given-names>M.</given-names></name> <name><surname>Hashino</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Cytadherence of Mycoplasma pneumoniae induces inflammatory responses through autophagy and toll-like receptor 4.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>82</volume> <fpage>3076</fpage>&#x2013;<lpage>3086</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01961-14</pub-id> <pub-id pub-id-type="pmid">24799628</pub-id></citation></ref>
<ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sluijter</surname> <given-names>M.</given-names></name> <name><surname>Spuesens</surname> <given-names>E. B.</given-names></name> <name><surname>Hartwig</surname> <given-names>N. G.</given-names></name> <name><surname>van Rossum</surname> <given-names>A. M.</given-names></name> <name><surname>Vink</surname> <given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>The Mycoplasma pneumoniae MPN490 and Mycoplasma genitalium MG339 genes encode reca homologs that promote homologous DNA strand exchange.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>77</volume> <fpage>4905</fpage>&#x2013;<lpage>4911</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00747-09</pub-id> <pub-id pub-id-type="pmid">19737894</pub-id></citation></ref>
<ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somarajan</surname> <given-names>S. R.</given-names></name> <name><surname>Al-Asadi</surname> <given-names>F.</given-names></name> <name><surname>Ramasamy</surname> <given-names>K.</given-names></name> <name><surname>Pandranki</surname> <given-names>L.</given-names></name> <name><surname>Baseman</surname> <given-names>J. B.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.</article-title> <source><italic>mBio</italic></source> <volume>5</volume>:<fpage>e01497-14</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.01497-14</pub-id> <pub-id pub-id-type="pmid">25139904</pub-id></citation></ref>
<ref id="B122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spahich</surname> <given-names>N. A.</given-names></name> <name><surname>St Geme</surname> <given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Structure and function of the <italic>Haemophilus influenzae</italic> autotransporters.</article-title> <source><italic>Front. Cell. Infect. Microbiol.</italic></source> <volume>1</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2011.00005</pub-id> <pub-id pub-id-type="pmid">22919571</pub-id></citation></ref>
<ref id="B123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spuesens</surname> <given-names>E. B. M.</given-names></name> <name><surname>Oduber</surname> <given-names>M.</given-names></name> <name><surname>Hoogenboezem</surname> <given-names>T.</given-names></name> <name><surname>Sluijter</surname> <given-names>M.</given-names></name> <name><surname>Hartwig</surname> <given-names>N. G.</given-names></name> <name><surname>van Rossum</surname> <given-names>A. M. C.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Sequence variations in RepMP2/3 and RepMP4 elements reveal intragenomic homologous DNA recombination events in Mycoplasma pneumoniae.</article-title> <source><italic>Microbiology (Reading)</italic></source> <volume>155</volume> <fpage>2182</fpage>&#x2013;<lpage>2196</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.028506-0</pub-id> <pub-id pub-id-type="pmid">19389769</pub-id></citation></ref>
<ref id="B124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spuesens</surname> <given-names>E. B.</given-names></name> <name><surname>Fraaij</surname> <given-names>P. L.</given-names></name> <name><surname>Visser</surname> <given-names>E. G.</given-names></name> <name><surname>Hoogenboezem</surname> <given-names>T.</given-names></name> <name><surname>Hop</surname> <given-names>W. C.</given-names></name> <name><surname>van Adrichem</surname> <given-names>L. N.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: An observational study.</article-title> <source><italic>PLoS Med.</italic></source> <volume>10</volume>:<fpage>e1001444</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1001444</pub-id> <pub-id pub-id-type="pmid">23690754</pub-id></citation></ref>
<ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spuesens</surname> <given-names>E. B.</given-names></name> <name><surname>Meyer Sauteur</surname> <given-names>P. M.</given-names></name> <name><surname>Vink</surname> <given-names>C.</given-names></name> <name><surname>van Rossum</surname> <given-names>A. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Mycoplasma pneumoniae infections&#x2013;does treatment help?</article-title> <source><italic>J. Infect.</italic></source> <volume>69</volume> <fpage>S42</fpage>&#x2013;<lpage>S46</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2014.07.017</pub-id> <pub-id pub-id-type="pmid">25267596</pub-id></citation></ref>
<ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname> <given-names>T. E.</given-names></name> <name><surname>Dyer</surname> <given-names>D. P.</given-names></name> <name><surname>Allen</surname> <given-names>J. E.</given-names></name></person-group> (<year>2023</year>). <article-title>The extracellular matrix and the immune system: A mutually dependent relationship.</article-title> <source><italic>Science</italic></source> <volume>379</volume>:<fpage>eab8964</fpage>. <pub-id pub-id-type="doi">10.1126/science.abp8964</pub-id> <pub-id pub-id-type="pmid">36795835</pub-id></citation></ref>
<ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Techasaensiri</surname> <given-names>C.</given-names></name> <name><surname>Tagliabue</surname> <given-names>C.</given-names></name> <name><surname>Cagle</surname> <given-names>M.</given-names></name> <name><surname>Iranpour</surname> <given-names>P.</given-names></name> <name><surname>Katz</surname> <given-names>K.</given-names></name> <name><surname>Kannan</surname> <given-names>T. R.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.</article-title> <source><italic>Am. J. Respir. Crit. Care Med.</italic></source> <volume>182</volume> <fpage>797</fpage>&#x2013;<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201001-0080OC</pub-id> <pub-id pub-id-type="pmid">20508214</pub-id></citation></ref>
<ref id="B128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>C.</given-names></name> <name><surname>Jacobs</surname> <given-names>E.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Characterization of pyruvate dehydrogenase subunit B and enolase as plasminogen-binding proteins in Mycoplasma pneumoniae.</article-title> <source><italic>Microbiology (Reading)</italic></source> <volume>159</volume> <fpage>352</fpage>&#x2013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.061184-0</pub-id> <pub-id pub-id-type="pmid">23197176</pub-id></citation></ref>
<ref id="B129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toyonaga</surname> <given-names>T.</given-names></name> <name><surname>Kato</surname> <given-names>T.</given-names></name> <name><surname>Kawamoto</surname> <given-names>A.</given-names></name> <name><surname>Kodera</surname> <given-names>N.</given-names></name> <name><surname>Hamaguchi</surname> <given-names>T.</given-names></name> <name><surname>Tahara</surname> <given-names>Y. O.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Chained structure of Dimeric F(1)-like ATPase in mycoplasma mobile gliding machinery.</article-title> <source><italic>mBio</italic></source> <volume>12</volume>:<fpage>e0141421</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.01414-21</pub-id> <pub-id pub-id-type="pmid">34281395</pub-id></citation></ref>
<ref id="B130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaca</surname> <given-names>D. J.</given-names></name> <name><surname>Thibau</surname> <given-names>A.</given-names></name> <name><surname>Schutz</surname> <given-names>M.</given-names></name> <name><surname>Kraiczy</surname> <given-names>P.</given-names></name> <name><surname>Happonen</surname> <given-names>L.</given-names></name> <name><surname>Malmstrom</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Interaction with the host: the role of fibronectin and extracellular matrix proteins in the adhesion of Gram-negative bacteria.</article-title> <source><italic>Med. Microbiol. Immunol.</italic></source> <volume>209</volume> <fpage>277</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1007/s00430-019-00644-3</pub-id> <pub-id pub-id-type="pmid">31784893</pub-id></citation></ref>
<ref id="B131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vizarraga</surname> <given-names>D.</given-names></name> <name><surname>Kawamoto</surname> <given-names>A.</given-names></name> <name><surname>Matsumoto</surname> <given-names>U.</given-names></name> <name><surname>Illanes</surname> <given-names>R.</given-names></name> <name><surname>Perez-Luque</surname> <given-names>R.</given-names></name> <name><surname>Martin</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>11</volume>:<fpage>5188</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-18777-y</pub-id> <pub-id pub-id-type="pmid">33057023</pub-id></citation></ref>
<ref id="B132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vizarraga</surname> <given-names>D.</given-names></name> <name><surname>Torres-Puig</surname> <given-names>S.</given-names></name> <name><surname>Aparicio</surname> <given-names>D.</given-names></name> <name><surname>Pich</surname> <given-names>O. Q.</given-names></name></person-group> (<year>2021</year>). <article-title>The sialoglycan binding adhesins of Mycoplasma genitalium and Mycoplasma pneumoniae.</article-title> <source><italic>Trends Microbiol.</italic></source> <volume>29</volume> <fpage>477</fpage>&#x2013;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2021.01.011</pub-id> <pub-id pub-id-type="pmid">33593698</pub-id></citation></ref>
<ref id="B133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waites</surname> <given-names>K. B.</given-names></name> <name><surname>Xiao</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Balish</surname> <given-names>M. F.</given-names></name> <name><surname>Atkinson</surname> <given-names>T. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Mycoplasma pneumoniae from the respiratory tract and beyond.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>30</volume> <fpage>747</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00114-16</pub-id> <pub-id pub-id-type="pmid">28539503</pub-id></citation></ref>
<ref id="B134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Widjaja</surname> <given-names>M.</given-names></name> <name><surname>Berry</surname> <given-names>I. J.</given-names></name> <name><surname>Jarocki</surname> <given-names>V. M.</given-names></name> <name><surname>Padula</surname> <given-names>M. P.</given-names></name> <name><surname>Dumke</surname> <given-names>R.</given-names></name> <name><surname>Djordjevic</surname> <given-names>S. P.</given-names></name></person-group> (<year>2020</year>). <article-title>Cell surface processing of the P1 adhesin of Mycoplasma pneumoniae identifies novel domains that bind host molecules.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>10</volume>:<fpage>6384</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-63136-y</pub-id> <pub-id pub-id-type="pmid">32286369</pub-id></citation></ref>
<ref id="B135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willby</surname> <given-names>M. J.</given-names></name> <name><surname>Krause</surname> <given-names>D. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Characterization of a Mycoplasma pneumoniae hmw3 mutant: Implications for attachment organelle assembly.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>184</volume> <fpage>3061</fpage>&#x2013;<lpage>3068</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.11.3061-3068.2002</pub-id> <pub-id pub-id-type="pmid">12003948</pub-id></citation></ref>
<ref id="B136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>C. R.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Sheppard</surname> <given-names>E. S.</given-names></name> <name><surname>Chopra</surname> <given-names>P.</given-names></name> <name><surname>Locklin</surname> <given-names>J.</given-names></name> <name><surname>Boons</surname> <given-names>G. J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Distinct Mycoplasma pneumoniae interactions with sulfated and sialylated receptors.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>88</volume>:<fpage>e00392-20</fpage>. <pub-id pub-id-type="doi">10.1128/IAI.00392-20</pub-id> <pub-id pub-id-type="pmid">32839185</pub-id></citation></ref>
<ref id="B137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Jiang</surname> <given-names>C.</given-names></name> <name><surname>You</surname> <given-names>X.</given-names></name> <name><surname>Zhu</surname> <given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Detection of Mycoplasma pneumoniae P1 subtype variations by denaturing gradient gel electrophoresis.</article-title> <source><italic>Diagn. Microbiol. Infect. Dis.</italic></source> <volume>78</volume> <fpage>24</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2013.08.008</pub-id> <pub-id pub-id-type="pmid">24268834</pub-id></citation></ref>
<ref id="B138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>T.</given-names></name> <name><surname>Kida</surname> <given-names>Y.</given-names></name> <name><surname>Kuwano</surname> <given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>Mycoplasma pneumoniae protects infected epithelial cells from hydrogen peroxide-induced cell detachment.</article-title> <source><italic>Cell. Microbiol.</italic></source> <volume>21</volume>:<fpage>e13015</fpage>. <pub-id pub-id-type="doi">10.1111/cmi.13015</pub-id> <pub-id pub-id-type="pmid">30702185</pub-id></citation></ref>
<ref id="B139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname> <given-names>T.</given-names></name> <name><surname>Kenri</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for Macrolide-Resistant M. pneumoniae.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>7</volume>:<fpage>693</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00693</pub-id> <pub-id pub-id-type="pmid">27242718</pub-id></citation></ref>
<ref id="B140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yiwen</surname> <given-names>C.</given-names></name> <name><surname>Yueyue</surname> <given-names>W.</given-names></name> <name><surname>Lianmei</surname> <given-names>Q.</given-names></name> <name><surname>Cuiming</surname> <given-names>Z.</given-names></name> <name><surname>Xiaoxing</surname> <given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.</article-title> <source><italic>Virulence</italic></source> <volume>12</volume> <fpage>788</fpage>&#x2013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2021.1889813</pub-id> <pub-id pub-id-type="pmid">33704021</pub-id></citation></ref>
<ref id="B141"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname> <given-names>I. A.</given-names></name> <name><surname>Hong</surname> <given-names>K. B.</given-names></name> <name><surname>Lee</surname> <given-names>H. J.</given-names></name> <name><surname>Yun</surname> <given-names>K. W.</given-names></name> <name><surname>Park</surname> <given-names>J. Y.</given-names></name> <name><surname>Choi</surname> <given-names>Y. H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.</article-title> <source><italic>BMC Infect. Dis.</italic></source> <volume>17</volume>:<fpage>402</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-017-2500-z</pub-id> <pub-id pub-id-type="pmid">28592263</pub-id></citation></ref>
<ref id="B142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Han</surname> <given-names>R.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>A. Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Mycoplasma hyopneumoniae evades complement activation by binding to factor H via elongation factor thermo unstable (EF-Tu).</article-title> <source><italic>Virulence</italic></source> <volume>11</volume> <fpage>1059</fpage>&#x2013;<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2020.1806664</pub-id> <pub-id pub-id-type="pmid">32815770</pub-id></citation></ref>
<ref id="B143"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yueyue</surname> <given-names>W.</given-names></name> <name><surname>Feichen</surname> <given-names>X.</given-names></name> <name><surname>Yixuan</surname> <given-names>X.</given-names></name> <name><surname>Lu</surname> <given-names>L.</given-names></name> <name><surname>Yiwen</surname> <given-names>C.</given-names></name> <name><surname>Xiaoxing</surname> <given-names>Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Pathogenicity and virulence of Mycoplasma genitalium: Unraveling Ariadne&#x2019;s Thread.</article-title> <source><italic>Virulence</italic></source> <volume>13</volume> <fpage>1161</fpage>&#x2013;<lpage>1183</lpage>. <pub-id pub-id-type="doi">10.1080/21505594.2022.2095741</pub-id> <pub-id pub-id-type="pmid">35791283</pub-id></citation></ref>
<ref id="B144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>Q.</given-names></name> <name><surname>Sun</surname> <given-names>P.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Tang</surname> <given-names>Y.</given-names></name> <name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2025</year>). <article-title>Protective immunity induced by a novel P1 adhesin C-terminal anchored mRNA vaccine against Mycoplasma pneumoniae infection in BALB/c mice.</article-title> <source><italic>Microbiol. Spectr.</italic></source> <volume>13</volume>:<fpage>e0214024</fpage>. <pub-id pub-id-type="doi">10.1128/spectrum.02140-24</pub-id> <pub-id pub-id-type="pmid">39831768</pub-id></citation></ref>
<ref id="B145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>Y. Y.</given-names></name> <name><surname>Wu</surname> <given-names>S. Z.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>L. Y.</given-names></name> <name><surname>Xu</surname> <given-names>J. X.</given-names></name> <name><surname>Huang</surname> <given-names>Z. H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>An analysis of 20 clinical cases of refractory mycoplasma pneumonia in children.</article-title> <source><italic>Ann. Palliat. Med.</italic></source> <volume>9</volume> <fpage>2592</fpage>&#x2013;<lpage>2599</lpage>. <pub-id pub-id-type="doi">10.21037/apm-19-497</pub-id> <pub-id pub-id-type="pmid">32921097</pub-id></citation></ref>
<ref id="B146"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Du</surname> <given-names>J. L.</given-names></name> <name><surname>Deng</surname> <given-names>D.</given-names></name> <name><surname>Gao</surname> <given-names>Y. L.</given-names></name> <name><surname>Wang</surname> <given-names>C. L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Correlation between the clinical severity, bacterial load, and inflammatory reaction in children with Mycoplasma Pneumoniae Pneumonia.</article-title> <source><italic>Curr. Med. Sci.</italic></source> <volume>40</volume> <fpage>822</fpage>&#x2013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1007/s11596-020-2261-6</pub-id> <pub-id pub-id-type="pmid">33123897</pub-id></citation></ref>
<ref id="B147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname> <given-names>L. L.</given-names></name> <name><surname>Wu</surname> <given-names>Y. M.</given-names></name> <name><surname>You</surname> <given-names>X. X.</given-names></name></person-group> (<year>2009</year>). <article-title>Mycoplasma lipoproteins and Toll-like receptors.</article-title> <source><italic>J. Zhejiang Univ. Sci. B</italic></source> <volume>10</volume> <fpage>67</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1631/jzus.B0820256</pub-id> <pub-id pub-id-type="pmid">19198025</pub-id></citation></ref>
<ref id="B148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>R.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name></person-group> (<year>2024</year>). <article-title>Reviewing advancement in Mycoplasma pneumoniae P30 adhesin protein provides insights for future diagnosis and treatment.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>15</volume>:<fpage>1515291</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2024.1515291</pub-id> <pub-id pub-id-type="pmid">39735188</pub-id></citation></ref>
</ref-list>
</back>
</article>